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ABSTRACT
Intravenous self-administration of drugs by experimental animals has importance as a laboratory model for the
study of drug abuse and for the investigation of the neurochemical mechanisms underlying the reinforcing properties
of drugs.

Utilizing the drug self-administration technique,

pharmacological investigations of the neurochemical basis
of drug reinforcement suggest that opiate reinforcement is
mediated through activation of central noradrenergic systems, whereas the reinforcing effects of psychomotor stimulants are mediated via

activation of dopaminergic systems.

The major purpose of the present study was to determine if
the alpha noradrenergic receptor agonist, clonidine, would
be self-administered by rats and furthermore to determine
if clonidine is self-administered for its positive reinforcing effects.

The latter was investigated by increasing the

response requirement to obtain each clonidine injection.
In view of the opiate-like effects of clonidine, the ability
of clonidine to maintain self-administration behavior in
rats self-administering the synthetic narcotic fentanyl was
investigated.

Also, the effect of response-contingent

naloxone injections on clonidine-reinforced responding were
compared with; their effect on fentanyl-reinforced responding.

Since stimulation of the noradrenergic system is sug-

gested to be involved in mediating the reinforcing effects

ii

of opiates, preliminary experiments compared the characteristics of clonidine-reinforced responding with the characteristics of f entanyl-reinf orced responding by independently
adding selected butyrophenones to the clonidine and fentanyl
solutions.

Under pentobarbital anesthesia male hooded rats

of the Long-Evans strain were implanted with chronic indwelling jugular catheters and allowed to self-administer either
clonidine (15 ug/Kg/injection), fentanyl (O.l and 1.0
ug/Kg/injection) or saline on a continuous reinforcement
schedule.

The drug solutions were delivered, in a constant

volume of 100 ul/Kg, into the vein in less than one second.
Subjects readily acquired the self-administration of clonidine and fentanyl (1 ug/Kg/injection) but not fentanyl
(0.1 ug/Kg/injection) nor saline.

Stable rates of clonidine

and fentanyl-reinforced responding were attained after 3 or
5 days, respectively.

When the fixed ratio (FR) requirement

to obtain each clonidine injection was increased from 1 to
3, a significant increase in lever pressing was observed;
however, total daily clonidine intake decreased significantly.
When the FR requirement was further increased from 3 to 10,
response rate increased so that total daily clonidine intake
at the FR-3 and FR-10 schedules of clonidine reinforcement
remained the same.

Substitution of clonidine (15 ug/Kg/

injection but not clonidine (1 ug/Kg/injection) nor saline
maintained self-administration behavior in rats previously
self-administering fentanyl. Extinction of self-administration

iii

behavior was observed following the substitution of both
clonidine (1 ug/Kg/injection) and saline for the fentanyl
solution.

Addition of naloxone (64 ug/Kg/injection) to the

clonidine and fentanyl solutions significantly decreased
fentanyl-reinforced responding but appeared to have no effect on clonidine-reinforced responding.

Fentanyl rein-

forced responding returned to pre-naloxone rates following
the removal of naloxone from the fentanyl solution.

Addi-

tion of either haloperidol or azaperone to the clonidine and
fentanyl solutionsiso that the subjects received 64 ug/Kg/
injection,. tended to decrease the rates of self-administration of rats previously self-administering either clonidine
or fentanyl alone. Removal of haloperidol and azaperone
from the clonidine and fentanyl solutions tended to result
in a return to pre-haloperidol and pre-azaperone response
rates.

Addition of aceperone (64 ug/Kg/injection) produced

no significant change in the rate of clonidine-reinforced
responding but resulted in a significant increase in the
rate of fentanyl-reinforced responding.

Self-administration

of clonidine by rats suggests that stimulation of central
alpha-noradrenergic receptors results in positive reinforcement.

Clonidine's self-administration by rats and its

ability to maintain self-administration behavior in rats
previously self-administering fentanyl suggests this drug
may have abuse potential.

Preliminary experiments suggest

some similarities between clonidine- and fentanyl-reinforced
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responding; however, the exact nature of these similarities remain to be determined.

The reinforcing effects of

clonidine, unlike the reinforcing effects of fentanyl,
seem to be mediated by opioid independent mechanisms.

v
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INTRODUCTION
Intravenous self-administration of drugs by experimental animals has importance as both a laboratory model
for experimental addiction and for the study of the neurochemical mechanisms underlying the reinforcing property of
drugs.

Utilizing the drug self-administration technique

it has been established that drugs of several pharmacological classes which are abused by humans for their positive reinforcing effects are also self-administered by experimental animals (Seiden and Dykstra, 1977).

The exact

nature of the reinforcing effects of drugs is unclear but
several investigations have suggested that catecholaminergic brain mechanisms are involved in mediating the positive reinforcing effects of opiates and psychomotor
stimulants (Pickens et al., 1968; Davis and Smith, 1972,
1973a, 1973b, 1974, 1975; Pozuello and Kerr, 1972; Glick
et al., 1973; Baxter et al., 1974; Davis et al., 1975;
Yokel and Wise, 1975, 1976; Wilson and Schuster, 1972, 1974).
Early experiments demonstrated that the catecholamine
synthesis inhibitor, alpha-methyl-para-tyrosine, blocked
the primary reinforcing action of morphine and psychomotor
stimulant drugs (Pickens et al., 1968; Davis and Smith,
1972, 1973; Pozuello and Kerr, 1972; Glick et al., 1973).
It was also reported that alpha-methyl-para-tyrosine prevented the establishment of conditioned reinforcement based
1

on the primary reinforcing properties of morphine and
d-amphetamine suggesting that the effect of alpha-methylpara-tyrosine was not due to a non-specific motor deficit
(Davis and Smith, 1973a, 1973b).
et al.,

In addition, Jonsson

(1969, 1971) reported that alpha-methyl-para- tyro-

sine blocked those subjective effects of d-amphetamine in
man which are considered related to its positive reinforcing effects.

Furthermore, Wilson and Schuster (1972)

demonstrated that the catecholamine receptor blocker, chlorpromazine, antagonized the positive reinforcing effects of
cocaine and other psychomotor stimulant compounds in rats.
Based on the above reports it was suggested that stimulation of catecholaminergic mechanisms of the brain underlie the positive reinforcing properties of opiates and
psychomotor stimulants.

However, because brain levels of

both dopamine and norepinephrine are depleted by alphamethyl-para-tyrosine and both dopaminergic and noradrenergic receptors are blocked by chlorpromazine, the exact role
r for each catecholamine in mediating the positive reinforcing effects of opiates and psychomotor stimulants remained
unclear.
Investigations attempting to differentiate between
dopaminergic and noradrenergic mechanisms utilized drugs
which selectively depleted brain norepinephrine but not
dopamine (Davis and Smith, 1974; Davis et al., 1975) are
selectively blocked dopaminergic but not noradrenergic receptors (or vice versa)

(Smith and Davis, 1973; Davis and
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Smith, 1974, 1975; Yokel and Wise, 1975, 1976).

Utilizing

the dopamine beta hydroxylase inhibitors, diethyldithiocarbamate (DDC) and U-14,624, to selectively deplete brain
norepinephrine, Davis and Smith (1974) and Davis et al.
(1975) reported that DDC and U-14,624 inhibited the primary
reinforcing action of morphine while U-14,624 inhibited the
primary reinforcing action of a-amphetamine. Furthermore,
DDC or U-14,624 pretreatment prevented the establishment
of a conditioned reinforcer based on primary reinforcement
associated with morphine and a-amphetamine injections
(Davis and Smith, 1974; Davis et al., 1975).
These data suggested that the reinforcing properties
of morphine and d-amphetamine are mediated by noradrenergic
and not dopaminergic brain mechanisms.

However, while

other studies provided further support that noradrenergic
mechanisms and not dopaminergic mechanisms are important
in mediating the reinforcing effects of morphine (Davis and
Smith, 1973, 1974, 1975) it appeared that dopaminergic and
not noradrenergic systems are important in mediating the
reinforcing effects of a-amphetamine (Davis and Smith,
1975; Yokel and Wise, 1975, 1976).
Smith and Davis (1973,1974) concluded that prevention
of reacquisition of morphine-reinforced responding by the
dopamine receptor blocking agent haloperidol was due to a
motor deficit produced by this drug and was not due to its
ability to block the reinforcing effects produced by morphine
3

self-administration.

This conclusion was supported by the

finding that haloperidol did not block the establishment
of a morphine-based conditioned reinforcer (Smith and Davis,
1973, 1974).

Therefore based on this evidence and the study

of Davis et al.

(1975)

the reinforcing property of morphine

seems to depend on noradrenergic and not dopaminergic mechanism in the brain.
On the other hand, Davis and Smith (1975) reported that
haloperidol blocked the primary reinforcing effects of
d-amphetamine and prevented the establishment of a conditioned reinforcer based on d-amphetamine as a primary reinforcer.

These data suggested that haloperidol can block the

reinforcing action of d-amphetamine without producing motor
deficits. Similarly, Yokel and Wise (1975, 1976) reported
that the dopamine receptor blockers pimozide and (+)-butaclamol blocked the reinforcing effects produced by d-amphetamine self-administration in rats.
Gunne et al.

In a clinical study,

(1972) reported that pimozide reduced amphet-

amine euphoria in humans.
Additional support for a role of dopamine but not
norepinephrine in the reinforcing action of psychomotor
stimulants was provided by Wilson and Schuster (1974) who
demonstrated that the alpha-noradrenergic receptor blocker,
phentolamine, had no effect on cocaine self-administration.
Furthermore, Yokel and Wise (1975, 1976) demonstrated that
the alpha-noradrenergic receptor blocker phenoxybenzamine
had no effect on a-amphetamine self-administration while
4

decreased rates of d-amphetamine self-administration

pro~

duced by phentolamine and the beta-adrenergic receptor
blocker propranolol were due to actions other than reward
attenuation.

Thus several studies suggest that dopamine

is an important mediator of the reinforcing effects of
psychomotor stimulants.

That direct stimulation of dopa-

mine receptors can result in positive reinforcement was
demonstrated by the finding that rats will self-administer
the dopamine receptor agonist apomorphine (Baxter et al.,
1974).
In conclusion the reinforcing property of opiates appear to depend on noradrenergic mechanisms (Smith and
Davis, 1973, 1974, 1975; Davis et al., 1975) whereas the
reinforcing actions of psychomotor stimulants appear to
depend on dopaminergic mechanisms (Davis and Smith, 1975;
Yokel and Wise, 1975, 1976).

Furthermore, self-administra-

tion of the dopamine receptor agonist apomorphine demonstrates that stimulation of central dopamine receptors
results in positive reinforcement (Baxter et al., 1974).
The major purpose of the present experiment was to
investigate if rats will self-administer the alpha-noradrenergic receptor agonist (Anden et al., 1970), clonidine.
It was hypothesized that clonidine would be self-administered by rats since i t had been previously reported (Smith
and Davis, 1975) that the reinforcing properties of opiates
are mediated through activation of noradrenergic mechanisms

5

in the brain.

It was also of interest to determine if

clonidine was self-administered for its positive reinforcing effects and not because of the drug's direct behavioral
effects. This was accomplished by increasing the response
requirement to obtain each clonidine injection.

Self-

administration rates to obtain morphine (Weeks, 1962) and
psychomotor stimulants (Pickens, 1968; Pickens and Harris,
1968; Pickens and Thompson, 1968; Goldberg et al., 197lc)
increase as the response requirement to obtain these drugs
is increased, therefore, it was hypothesized that if clonidine was self-administered for its positive reinforcing
effects self-administration rates to obtain clonidine
injections would increase as the response requirement to
obtain clonidine injections was increased.
Fentanyl is a synthetic narcotic which is known to be
self-administered by rats (Lal et al., 1977).

Since the

noradrenergic system seems to be involved in mediating narcotic reinforcement (Davis and Smith, 1973, 1974, 1975),
preliminary experiments compared the characteristics of
fentanyl-reinforced responding with the characteristics of
clonidine-reinforced responding.

For this purpose three

different butyrophenone neuroleptics with differential
potencies versus dopaminergic and noradrenergic receptors
were added to the clonidine and f entanyl solutions for selfadministra tion of the drug mixture.

The effect of the

butyrophenones on clonidine-reinforced responding were
compared to their effect on fentanyl-reinforced responding.
6

The butyrophenones were added to the clonidine and f entanyl
solutions for self-administration of the drug mixture since
the effect of intraperitoneal administration of these drugs
was already known.

Furthermore, this procedure may have

potential for the treatment of drug abuse since concomitant
administration of an antagonist with the reinforcing agonist should result in extinction of the drug-seeking behavior.

Because butyrophenone' beuroleptics decrease·nor-

adrenergic transmission and narcotic

r~inforcement

depends

on activation of noradrenergic mechanisms, it was hypothesized that addition of the butyrophenones to the clonidine
and fentanyl solutions would result in decreased rates of
clonidine- and fentanyl-reinforced responding.
Finally, it has been demonstrated that clonidine and
opiates have similar actions on noradrenergic neurons
(Redmond, 1977) and produce similar pharmacological effects such as inhibition of narcotic withdrawal (Tseng et
al., 1975; Vetulani and Bednarczyk, 1977; Fielding et al.,
1977, in press; Gold et al., 1978) and analgesia (Paalzow,
1974; Paalzow and Paalzow, 1976; Schmitt et al., 1974;
Sewell and Spencer, 1975; Fielding et al., 1977, in press;
Bentley et al., 1977).

In view of these similarities the

ability of clonidine to maintain fentanyl-reinforced responding was investigated by substituting clonidine for
the f entanyl solution.

It was hypothesized that clonidine

would maintain the previously established self-administration behavior.
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All actions of narcotics, including their positive reinforcing action (Goldberg et al., 1972) and their ability
to impart secondary reinforcing properties on previously
neutral stimuli (Davis and Smith, 1974a; Marcus et al.,
1976), are antagonized by the narcotic antagonist naloxone.
In contrast, however, the pharmacological actions of clonidine which are similar to those produced by narcotics are
not antagonized by naloxone suggesting that these actions
of clonidine occur through opioid independent mechanisms
(Paalzow and Paalzow, 1976; Fielding et al., 1977, in press;
Meyer et al., 1977; Washton et al., 1978).

A preliminary

experiment was performed to determine the effect of adding
naloxone to the clonidine and fentanyl solutions for selfadministration of the drug mixture. The effect of naloxone
on clonidine-reinforced responding was compared to its effect on fentanyl-reinforced responding to determine if
clonidine reinforcement is mediated via opioid dependent
mechanisms.

It was hypothesized that naloxone would de-

crease fentanyl-

but not clonidine-reinforced responding.

8

LITERATURE REVIEW
CLONIDINE: ITS ACTIONS ON CENTRAL NEUROTRANSMITTER SYSTEMS
A.

Clonidine and the Central Noradrenergic System
Clonidine (2-(2,6-dichlorophenylamino-2-imidazoline

hydrochloride) is a very potent antihypertensive drug
(Nickerson and Ruedy, 1975) which can stimulate peripheral alpha-adrenergic receptors (Boissier et al., 1968;
Constantine and Mcshane, 1968).

However, the antihyperten-

sive action of clonidine appears to be mediated by alphaadrenergic stimulatory activity at alpha-adrenergic receptors within the medulla oblongata (Kobinger and Walland,
1967; Schmitt and Schmitt, 1970; Van Zwieten, 1975) which
are inhibitory to sympathetic nerve stimulation, thereby
reducing sympathetic outflow from the vasomotor center of
the medulla.
Studies on the central noradrenergic system show that
clonidine reduces the turnover rate of norepinephrine in
whole brain (Anden et al., 1970) and some of its regions
(Rochette et al., 1974) as measured by a slowing of the
disappearance of this amine following synthesis inhibition
with the tyrosine hydroxylase inhibitor, alpha-methyl-paratyrosine.

This effect was counteracted by pretreatment

with the alpha-noradrenergic receptor blocking agents haloperidol and phenoxybenzamine (Anden et al., 1970), thus sugwesting a post-synaptic noradrenergic receptor stimulating
action of clonidine.
9

Clonidine has also been found to reduce the rate of
formation of norepinephrine from labelled tyrosine (Rochette
et al., 1974) and lower brain levels of the maj.or norepinephrine metabolite 3-methoxy-4-hydroxy-phenylglycol (MOPEG)
(Braestrup, 1974).
Whole brain levels of norepinephrine are not changed
by low (30 or 400 ug/Kg) doses of clonidine (Anden et al .. ,
1970).

However, higher doses (0.5-2.5 mg/kg) produce a

significant increase in norepinephrine levels in all brain
regions except the striatum (Laverty and Taylor, 1969).
Radioisotope studies indicated an increase in norepinephrine
storage without significant changes in metabolism.
Clonidine was found to diminish the stimulation-evoked
tritum overflow from rat cerebral cortical slices preincubated with tritrated noradrenaline (Farnebo and Hamberger,
1971; Starke and Montel, 1973) and abolish the increase in
tritium overflow produced by phenoxybenzamine and phentolamine (Farnebo and Hamberger, 1971; Starke and Mantel, 1973)
but not cocaine (Starke and Montel, 1973).

Since phenoxy-

benzamine and phentolamine block alpha-noradrenergic receptors while cocaine primarily blocks the reuptake of norepinephrine i t was conlcuded that clonidine stimulates alphareceptors.
Although the latter experiments and those of Anden et
al.

(1970, 1976) suggest that clonidine stimulates central

post-synaptic alpha-noradrenergic receptors, some postsynaptic alpha-noradrenergic receptors appear to be inhibited
10

by the drug.

While clonidine has no significant effect on

basal levels of cyclic 3',5' adenosine monophosphate in incubated slices of rat cerebral cortex (Skolnick and Daly,
1975a) it antagonized the norepinephrine elicited accumulation of cyclic AMP to a degree which corresponds to the
alpha adrenergic component of the norepinephrine response.
Clonidine also completely blocked the increase in cyclic
AMP produced by methoxamine (Skolnick and Daly, 1975b), an
alpha adrenergic agonist.

However, clonidine did not atten-

uate the accumulation of cyclic AMP elicited by maximal
concentrations of the beta adrenergic agonist, isoproteronol, and markedly potentiated the effects of submaximal
concentration of this agent (Skolnick and Daly, 1975a) . The
locus of clonidine's action appears to be post-synaptic
since destruction of pre-synaptic noradrenergic terminals
with 6-hydroxydopamine had no effect on the norepinephrine
and isoproteronol induced accumulation of cyclic AMP
(Skolnick and Daly, 1976).

Furthermore, the results of

Skolnick and Daly (1975a) suggest that clonidine may sensitize the beta-adrenergic receptor.
In addition to its action on central post-synaptic
noradrenergic receptors, clonidine also stimulates presynaptic noradrenergic receptors.

Svensson et al.

(1975)

demonstrated that clonidine, administered intravenously or
applied microiontophoretically, inhibited the spontaneous
firing of brain norepinephrine containing neurons (Dahlstrom
and Fuxe, 1965) in the locus coeruleus.
11

These findings

suggest that neurons in the locus

coer~leus

possess pre-

synaptic alpha-adrenergic receptors located on or near their
soma and that activation of these receptor sites by clonidine may be responsible for its ability to inhibit the
activity of these noradrenergic neurons.
for a

~resynaptic

Further support

noradrenergic receptor stimulation by

clonidine was provided by Cedarbaum and Aghajanian (1976)
who found that the presynaptic alpha-noradrenergic receptor
blocker (Cubeddu et al., 1974), piperoxane, blocked the
clonidine-induced inhibition of firing of locus coeruleus
neurons.

B.

Clonidine and the Central Serotoninergic System
Clonidine has been found to affect the central sero-

toninergic system.

The majority of evidence indicates that

clonidine's effect on this system is indirect and probably
occurs via central noradrenergic neurons.

However, a direct

action of clonidine on the central serotoninergic system
cannot be ruled out.
Anden et al.

(1970) found that clonidine reduced the

turnover rate of serotonin as measured by a slowing of the
disappearance of this amine in rat brain after synthesis
inhibition with the tryptophan hydroxylase inhibitior alphapropylacetaminde.

This effect was counteracted by pretreat-

ment with the noradrenergic receptor blocking agents phenoxybenzamine and haloperidol suggesting that noradrenergic
receptor stimulation directly or indirectly inhibits the

12

activity of serotonin neurons.

Similar reductions in the

turnover of serotonin in whole brain and some of its regions
were observed by Scheel-Kruger and Hasselager (1974) and
Rochette and Bralet (1975).
Although clonidine does not affect whole brain levels
of serotonin in rats and mice (Anden et al., 1970; Maj et
al., 1973) it markedly elevates the serotonin content of
the pons plus medulla (Maj et al., 1973), a region rich in
serotonin neurons (Dahlstrom and Fuxe, 1965).

Furthermore,

decreased whole brain levels of serotonin produced by L-dopa
were prevented by clonidine (Maj et al., 1973).
Apomorphine and L-dopa induced elevation of brain concentrations of the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA) was antagonized by clonidine although
clonidine by itself did not affect 5-HIAA levels (Maj et al.,
1973).

However, when measured at a different time follow-

ing clonidine administration Scheel-Kruger and Hasselager
(1974) reported that clonidine produced a significant decrease in the concentration of 5-HIAA. These findings suggest that clonidine may inhibit the release of serotonin.
Following blockade of central noradrenergic receptors
by haloperidol or phenoxybenazamine, Anden et al.

(1970)

found that clonidine did not produce effects on spinal reflexes similar to those observed after treatment with 5-hydroxytryptophan indicating that clonidine has no direct
stimulating action on cerebral serotonin receptors like
LSD (Anden et al., 1968).
13

Utilizing single cell recording techniques,Svensson
et al.

(1975) investigated the effect of clonidine on the

firing rate of serotonin neurons.

When administered intra-

venously clonidine inhibited the firing rate of a great
majority of serotonin neurons in the midbrain dorsal raphe
nucleus.

However, this action did not seem to be a direct

one since clonidine had relatively weak or variable effects
when applied microiontophoretically to raphe neurons. These
findings suggest that clonidine-induced depression of raphe
firing may be secondary to an impairment in noradrenergic
transmission as prior destruction of noradrenergic neurons
by 6-hydroxydopamine rendered the raphe neurons insensitive
to the depressant effect of intravenous clonidine.

Also

much higher doses of clonidine, which have been reported to
have post-synaptic receptor activity (Anden et al., 1970),
reversed the depression produced by a low dose of clonidine
itself.

C.

Clonidine and the Central Dopaminergic System
The effect of clonidine on the central dopaminergic sys-

tem is not well documented, however, investigations studying this interaction demonstrate in general that clonidine
has no effect on the central dopaminrgic system.
Anden et al.

(1970) measured the effect of clonidine on

the turnover rate of dopamine in rat brain as measured by
disappearance of this amine following synthesis inhibition
with the tyrosine hydroxylase inhibitior alpha-methyl-para14

tyrosine and found that clonidine had little or no effect.
It was also demonstrated that clonidine did not change
levels of dopamine in whole brain.
Treatment with reserpine plus the dopamine precursor
L-dopa, produces turning to the operated side in rats with
a unilateral lesion of the corpus striatum (Anden et al.,
1966).

However, no turning to the operated side was ob-

served in rats with one intact corpus striatum after treatment with reserpine plus clonidine, indicating that clonidine has no stimulating effect on central dopamine receptors
(Anden et al., 1970).
Clonidine had no effect on dopaminergic neuronal firing
when applied microiontophoretically to dopaminergic neuronal
soma in the substantia nigra (zona compacta) and adjacent
medial ventral tegmentum; however, apomorphine inhibited
dopaminergic neuronal firing (Aghajanian and Bunney ,1977).
These findings also suggest a lack of dopaminergic receptor
stimulation by clonidine.

D.

Clonidine and

O~er

Central Transmitter Systems

Recent evidence suggests that clonidine may have effects on other central neurotransmitter systems.
Maj et al.

(1975) reported that atropine and scopol-

amine block clonidine-induced decreases in locomotor activity of rats, indicating a possible cholinergic mechanism
of action.

It was also found that clonidine increased the

acetylcholine concentration in rats' striatum but did not
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influence its content in cortex, hypothalamus, thalamus,
pons or medulla oblangata (Maj et al., 1975).
The possible involvement of central histamine H2 receptors in mediating hhe hypotensive effect of clonidine
has recently been demonstrated (Karppanen, 1976).

Further-

more, it was found that histamine, clonidine or norepinephrine decreased the firing rate of cerebral cortical
neurons, when applied microiontophoretically (Sastry and
Phyllis, 1977).

Metiamide, an H2-histamine receptor antag-

onist, reversed the depressant effects of clonidine and
histamine but not norepinephrine.

These results suggest

that clonidine can activate histamine H2-receptors on central neurons.
PSYCHOPHARMACOLOGICAL ACTIONS OF CLONIDINE
~.

Motor Behavior
1.

Rotorod Test
Rotorod performance is measured by the ability of

an animal to stay on a revolving drum or cylinder over a
period of time. Clonidine (1.0 mg/Kg, i.p.) reduced rotorod performance in rats (Laverty and Taylor, 1969) and
mice (EDso 0.24 mg/Kg, s.c.)
2.

(Cornfeldt et al., 1978).

Open Field and Hole Test
In the open field and hole test, clonidine (0.1

mg/Kg) was reported to potentiate the depressant effect
on rats behavior produced by intracerebroventricular administration of 6-hydroxy-dopamine (Herman et al., 1976).
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3.

Locomotor Activity
Locomotor activity has been suggested to be con-

trolled by both the dopaminergic and noradrenergic system
within the brain (Anden et al., 1976).

Locomotor activity

in laboratory animals is often measured by the number of
times the subject interrupts a light beam in a photocell
chamber (Seiden and Dykstra, 1977).

Each time the light

beam is interrupted a count is recorded and thus the number of counts varies proportionately with the subject's
locomotor activity.
When measured in the above manner, clonidine (0.0525.0 mg/Kg) has been reported to produce a dose-dependent
decrease in the locomotor activity of mice and rats (Maj
et al., 1972, 1975; Tilson et al., 1977) in spite of marked
sympathomimetic signs (Maj et al., 1972).
While clonidine (1-25 mg/Kg) potentiated the decrease
in locomotor activity in mice produced by pretreatment with
the neuroleptic, spiroperidol (Maj et al., 1972), it did
not influence the depression of locomotor activity produced
by pretreatment with reserpine (Anden et al., 1970a, 1973,
1976; Maj et al., 1972; Menon et al., 1977), alpha-methylpara-tyrosine (Anden et al., 1972; Maj et al., 1972), FLA63 or phenoxybenzamine (Maj et al., 1972) despite marked
sympathomimetic signs.

However, clonidine (1-25 mg/Kg) po-

tentiated the partial reversal of locomotor activity produced by apomorphine in mice pretreated with reserpine
(Anden et al., 1970a, 1973, 1976; Jenner and Pycock, 1976;
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Maj et al., 1972; Menon et al., 1977), alpha-methyl-paratyrosine (Anden et al., 1970a, Maj et al. , 1972) and FLA-63
(Maj et al., 1972) at doses which do not interfere with
the metabolism of apomorphine (Anden et al . , 1973).

Further-

more, increased locomotor activity induced by the dopamine
receptor stimulant metatyrosine (Anden et al., 1973) or LSD
(Menon et al., 1977) in reserpine treated mice was enhanced
by clonidine (1.0 mg/Kg, i.p.) pretreatment.

Clonidine

(5 and 25 mg/Kg) did not potentiate the antagonism of phenoxybenzamine induced decrease in locomotor activity produced by
apomorphine, but resulted in a decreased effect of apomorphine (Maj et al., 1972). The potentiation by clonidine of
the apomorphine-induced locomotor stimulation in reserpinetreated mice was almost completely blocked by phenoxybenzamine (20 mg/Kg), partially antagonized by tolazoline (50
mg/Kg) and not significantly affected by yohimbine (3 and
10 mg/Kg)

(Anden et al., 1976).

Locomotor activity decreased by clonidine in mice and
rats was antagonized by atropine and scopolamine (Maj et al.,
1975).

The peripheral cholinolytics atropine methyl nitrate

and scopolamine butyl bromide were ineffective in mice and
partly effective in rats in antagonizing the clonidineinduced decrease in locomotor activity · (Maj et al., 1975).
In conclusion, these studies demonstrate that clonidine
produces a dose-dependent decrease in the locomotor activity
of both mice and rats.

However, clonidine may potentiate
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the increased locomotor activity produced by other drugs
under certain pharmacological conditions.

Results of stu-

dies investigating the mechanism by which clonidine affects
locomotor activity suggest the involvement of cholinergic
(Maj et al., 1975) and noradrenergic (Anden et al., 1976)
mechanisms.

These studies also strengthen the suggestion

of Maj et al., 1972 that stimulation of both dopaminergic
and noradrenergic systems are required for maximal locomotor activity.
4.

Circling
Circling or rotational behavior in rats with uni-

lateral lesions of the nigrostriatal pathway is considered
to be a dopamine dependent behavior.

This consideration

is based upon the finding that administration of drugs which
increase dopaminergic activity in the central nervous system after the lesion produce rotational behavior (Ungerstedt
et al., 1969).
Using a rotometer which measures the number of full
turns the subject makes per unit time, Satoh et al., 1976
reported that, in rats with unilateral 6-hydroxydopamineinduced lesions of the substania nigra, intraventricular
injection of apomorphine, dopamine and norepinephrine at
doses of 64 ug induced turning of the rats towards the intact side whereas intraventricular injection of methamphetamine (250 ug) induced turning towards the lesioned side.
On the other hand, intraventricular injection of clonidine
(64 ug)

did not induce any turning.
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It was suggested by

Satoh et al. that dopamine, norepinephrine and apomorphine
directly stimulate the supersensitive dopamine receptors on
the side of the lesion whereas methamphetamine indirectly
stimulates dopamine receptors on the intact side.

Since

clonidine is considered to be an alpha-noradrenergic agonist (Anden et al., 1970), norepinephrine-induced turning
was considered to be due to a non-specific stimulation of
dopamine receptors.
Direct injection of clonidine (100 ug)

into one stri-

atum of rats with intact nigrostriatal systems did not produce circling, nor did this pretreatment result in circling
following the subcutaneous administration of the dopamine
agonist apomorphine (0.5 mg/Kg)

(Jenner and Pycock, 1976).

However, circling behavior induced by either apomorphine
(0.25 mg/Kg, s.c.) or d-amphetamine (3 mg/Kg, i.p.) in mice
with unilateral lesions of the nigriostriatal pathway was
potentiated by pretreatment with clonidine (0.06-2.0 mg/Kg,
i.p.)

(Jenner and Pycock, 1976; Pycock et al., 1977).

In

contrast to this latter finding, Cornfeldt et al., 1978
reported that clonidine (ED50 0.08 mg/Kg, i.p.) blocked
amphetamine- but not apomorphine-induced circling in rats
with striatal lesions.
Unilateral electrolytic destruction of the locus
coeruleus in rats results in spontaneous ipsilateral turning behavior which is soon replaced by contralateral turning (Pycock et al., 1975).

One week after locus coeruleus

lesioning, when spontaneous turning has stopped, intraperi20

toneal administration of the dopamine agonists apomorphine,
d-amphetamine and piribedil but not the noradrenergic agonist, clonidine (0.05-0.5 mg/Kg) elicited contralateral
circling (Donaldson et al., 1977).

It was suggested by

Donaldson et al., that circling behavior seen after unilateral locus coeruleus lesions was the result of supersensitive striatal dopamine receptors in the nigrostriatal pathway on the side of the lesion.
The results of the above studies investigating the
effect of clonidine on rotational behavior suggest that
clonidine does not stimulate dopamine receptors and provides
further evidence that rotational behavior depends on dopaminergic and not noradrenergic mechanisms.

However, it

appears rotational behavior induced by dopaminergic agonists may be modified by clonidine (Jenner and Pycock, 1976;
Pycock et al., 1977).
5.

Stereotypy
Stereotypic behavior consists of the repeated spon-

taneous occurrence of motor responses which are within the
animal's normal behavior such as licking, sniffing, gnawing
and head bobbing (Seiden and Dykstra, 1977).

Stereotypic

behavior is believed to be the result of heightened doparninergic activity in the corpus striatum (Seiden and Dykstra,
1977) .

Both direct and indirect dopaminergic agonists such

as apomorphine and d-amphetarnine, elicit stereotypic behavior (Seiden and Dykstra, 1977) .
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Intraperitoneal administration of clonidine (0.5 mg/Kg)
did not affect the stereotyped behavior induced by apomorphine (0.1-5.0 mg/Kg, s.c.) in rats (Jenner and Pycock, 1976;
Pycock et al., 1977) suggesting that clonidine does not stimulate striatal dopamine receptors.
6.

Catalepsy
Catalepsy is generally defined as the condition of

an animal when it is amenable to being positioned in awkward
positions by an experimenter and where these postures are
m~intained

1971).

until altered by the experimenter (Rech and Moore,

Catalepsy may be caused by decreased dopaminergic

activity within the nigrostriatal system (Seiden and Dykstra,
1977).

Neuroleptic drugs, such as haloperidol, which de-

crease dopaminergic activity induce catalepsy (Rech and
Moore, 19 71) •
Clonidine (0.5 mg/Kg, i.p.) has been reported to potentiate the cataleptic action of haloperidol (0.1-2.0 mg/Kg,
i.p.) in rats; however, this action is probably non-specific
and is the result of clonidine's sedative effect (Jenner and
Pycock, 1976; Pycock et al., 1977).
7.

Tremor-like Motor Dysfunctions (wet-shakes)
"Wet dog shakes" in rats have been suggested to be

due to heat gain mechanisms (Wei et al., 1974).

Clonidine

has been reported to inhibit the "wet dog shakes" produced
in rats by immersion in ice-cold water (Wei, 1975) or by
administration of the drug AG-3-5[1-(2-hydroxyphenyl)-422

(3-nitrophenyl)-1,2,3,6 tetrahydropyrimidine-2-one]
1976).

(Wei,

Jahn and Mixich (1976) reported that clonidine

(0.01-0.1 mg/Kg, s.c.) produced a dose-dependent reduction
of "wet dog shakes" produced by the benzylideneaminooxycarbonic acid derivative Sgd 8473.

The ability of clonidine

to reduce "wet dog shakes" may be non-specific since several
other drugs including narcotics, narcotic antagonists, psychosedatives, cocaine, dl-amphetamine and apomorphine were
also effective in this regard (Jahn and Mixich, 1976) .

B.

Operant Behavior
1.

Schedule Control
Clonidine (0.006-.3 mg/Kg) produced a dose-depend-

ent suppression of operant behavior maintained by fixedratio (Colelli et al., 1976), fixed-interval (Harris et al.,
1977) and differential reinforcement of low rates (Tilson
et al., 1977) schedules of food-reinforced responding.
When chronically administered, tolerance to the behavioral depressant effect of clonidine on food-reinforced
responding was evident after 5 days and was complete by 2
weeks (Meyer et al., 1977).

Abrupt termination of clonidine

treatment in tolerant rats resulted in an abstinence reaction characterized by suppression of operant behavior for
as long as one week (Meyer et al., 1977).
Clonidine antagonized the disruption of fixed-ratio
operant behavior produced by naloxone injection in morphinedependent rats (Colelli et al., 1976).
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Whereas the rate decreasing effect of apomorphine under a fixed-interval schedule of food reinforcement was
potentiated by naloxone, the effect of clonidine was unaltered

~Harris

et al., 1977).

At doses capable of suppress-

ing operant behavior in morphine-dependent rats (Gellert
and Sparber, 1977), naloxone failed to disrupt operant behavior in clonidine tolerant rats (Meyer et al., 1977).
Suppression of fixed-ratio food-reinforced operant
behavior in rats produced by depletion of brain catecholamines with

alpha-methyl-para-~yrosine

or tetrabenzaine was

not antagonized by apomorphine or clonidine; however, L-dopa
reversed the suppression produced by alpha-methyl-paratyrosine but not tetrabenazine (Ahlenius et al., 1971).
In rats trained to respond on a fixed-interval schedule
•
of water-reinforced responding, Glick and Cox (1976) reported that both apomorphine (0.25-10.0 mg/Kg) and clonidine
(0.002-0.l mg/Kg) produced a dose-dependent suppression of
responding.

Following frontal cortical lesions the sensi-

tivity to apomorphine but not clonidine was increased
(Glick and Cox, 1976).
Intraventricular administration of 1-norepinephrine
(10 ug), but not clonidine (0.5 ug), restored the doserelated decrease in the rate of substania nigra self-stimulation produced by norepinephrine synthesis

inhibition with

diethyldithiocarbamate (Belluzi et al., 1975).
In summary, these findings indicate that clonidine
produces a suppression of operant behavior maintained by
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different schedules of food reinforced responding and by a
fixed-interval schedule of water-reinforced responding. Because clonidine also reduces food intake (Le Douarec et al.,
1972), water intake (Le Douarec, 1971) and locomotor activity (Tilson et al., 1977) in rats it cannot be stated
with certainty whether clonidine suppresses operant behavior
for food and water reinforcement because of its anorexic and
adipsic effect or its sedative effect. Since a reduction in
operant behavior is observed following a reduction in noradrenergic transmission (Belluzi et al., 1975) the suppressant effect of clonidine on operant behavior may be related
to its stimulatory action at pre-synaptic alpha-adrenergic
receptors, thus reducing noradrenergic transmission.

This

is supported by the finding that norepinephrine but not
clonidine (Belluzi et al., 1975) will restore operant behavior suppressed by norepinephrine, synthesis inhibition.
Finally, the suppressant action of clonidine on operant responding appears to be independent of an action on endogenous opioid mechanisms since naloxone fails to alter the
effect of clonidine (Harris et al., 1977; Gellert and
Sparber, 1977).
2.

Conditioned Avoidance Response
In the conditioned avoidance response (CAR) paradigm

animals are trained to avoid an aversive stimulus by responding during a stimulus which precedes the delivery of the
aversive stimulus (Seiden and Dykstra, 1977).
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Animals thus

trained become conditioned to avoid the aversive stimulus
by responding during the pre-aversive stimulus signal.

If

the subject responds during the aversive stimulus it is
considered to have ·escaped the aversive stimulus.

Both

dopamine and norpinephrine are considered to be involved in
the mediation of an avoidance response (for review see
Seiden and Dyks'tra, 1977).

Neuroleptic drugs selectively

disrupt avoidance responding at doses which do not disrupt
escape (for review see Seiden and Dykstra, 1977).
Laverty and Taylor (1969) reported that intraperitoneal administration of clonidine (0.1-1.0 mg/Kg), in rats
trained to climb a pole to avoid a shock, produced a dosedependent inhibition of conditioned avoidance behavior.
This may be a non-specific effect, however, and may be the
result of sedation since these doses have been reported to
decrease locomotor activity (Maj et al., 1972, 1975; Tilson
et al., 1977).
Depletion of brain catecholamines by 6-hydroxydopamine
has been demonstrated to interfere with the maintenance and
acquisition of avoidance responding (for review see Seiden
and Dykstra, 1977) •

Suppression of a previously learned

conditioned avoidance response in rats produced by intraventricular administration of 6-hydroxydopamine was reported
to be reversed by intraventricular administration of norepinephrine, dopamine, L-dopa or by intraperitoneal administration of amphetamine, phenylzine, desipramine, apomorphine
and clonidine (Ruiz and Monti, 1975; Lenard and Beer, 1975).
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Pretreatment with the neuroleptic, spiroperidol, prevented
the recovery produced by the above drugs, however, clonidineinduced recovery was least affected (Lenard and Beer, 1975).
The above studies demonstrate an effect of clonidine
on conditioned avoidance responding and support the suggestion for the involvement of both dopaminergic and noradrenergic systems in its mediation.
3.

Brain Self-Stimulation
It is well established that laboratory animals will

lever press to obtain electrical stimulation when electrodes
are placed in various brain areas.

Investigations of the

neurochemical mechanisms underlying the reinforcing property of intracranial self-stimulation(ICSS) suggest the
possible involvement of both dopaminergic and noradrenergic
systems (for review see Seiden and Dykstra, 1977).

However,

it has recently been reported that a stronger case can be
made for the involvement of dopaminergic mechanisms (for
review see Fibiger, 1978).
Utilizing a shuttle-box technique that provides a
rate-independent index of the rewarding and aversivecomponents of ICSS, Hunt et al.

(1976) reported that intraperi-

toneal administration of clonidine (.004-.063 mg/Kg) produced a dose-dependent increase in the latency to initiate
lateral hypothalamic ICSS, whereas the latency to escape
ICSS was largely unaffected except at doses which caused
depression of performance.

The peripheral alpha-adrenergic
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agonist 1-phenylephrine (0.05-1.0 mg/Kg) was ineffective in
this regard indicating that inhibition of reward by clonidine
was a central effect (Hunt et al., 1976).

Clonidine acted

in a synergistic manner with the catecholamine synthesis inhibitor, alpha-methyl-para-tyrosine (250 mg/Kg)
increase

(~500%)

to greatly

the initiate latency magnitude and prolong

the duration of inhibition of reward while leaving the escape latency magnitude largely unaffected (Hunt et al.,
1976).

Whereas administration of clonidine (0.016-0.064

mg/Kg) or alpha-methyl-para-tyrosine alone 24 hours before
testing had no effect, when given together they produced a
complete elimination of the initiate behavior while escape
behavior remained unaffected (Hunt et al., 1976).
High rates of lateral hypothalamic ICSS in squirrel
monkeys were blocked by clonidine (0.1 mg/Kg), whereas in
the same animal caudate ICSS was much less affected at this
dose (Spencer and Revzin, 1976).

A higher dose of clonidine

(0.25 mg/Kg) which produced sedation depressed ICSS equally
well at both sites (Spencer and Revzin, 1976).

In contrast,

amphetamine (10 mg/Kg) and chlorpromazine (0.5 or 1.0 mg/Kg)
had significantly more effect on caudate ICSS than lateral
hypothalamic ICSS (Spencer and Revzin, 1976).
Depression of lateral hypothalamic ICSS produced by
clonidine (0.15 mg/Kg) was antagonized by doses of piperoxane (1.7-15.0 mg/Kg) which selectively block pre-synaptic
alpha adrenergic or adrenaline-receptors while a higher dose
of piperoxane (45 mg/Kg), phentolamine (0.55-15.0 mg/Kg) and
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phenoxybenzamine (0.1-10.0 mg/Kg) which block both pre- and
post-synaptic receptors were ineffective (Franklin and
Herberg, 1977).
At doses not producing motor deficits, Vetulani et al.
(1977) reported that intraperitoneal administration of clonidine (0.05-.20 mg/Kg) in rats produced a dose-dependent
depression of medial forebrain bundle ICSS.

Furthermore,

clonidine (0.10 mg/Kg) blocked the facilitation of medial
forebrain bundle ICSS produced by d-amphetamine (0.5 mg/Kg)
(Vetulani et al., 1977).

Since

~-amphetamine

has been re-

ported to release norepinephrine it was suggested that clonidine' s blockade of medial forebrain bundle ICSS was the
result of its stimulatory action at pre-synaptic alphanoradrenergic receptors or its blockade of post-synaptic
noradrenergic receptors (Vetulani et al., 1977).
Based on the results of the above experiments demonstrating a depression of ICSS by clonidfueit is not surprising that inhibition of substania nigra ICSS in rats produced
by the norepinephrine synthesis inhibitors, diethyldithiocarbamate (Belluzi et al., 1975) or inhibition of lateral
hypothalamic ICSS by the norepinephrine synthesis inhibitor,
disulfiram (Shaw and Rolls, 1976) was not restored by clonidine (0.5-3 ug, i.v.t. or 0.037-3 mg/Kg, i.p.).
In conclusion these findings suggest that clonidine
attenuates the rewarding component of ICSS.

Furthermore,

this action appears to be mediated through its stimulatory
action at central pre-synaptic alpha-noradrenergic receptors
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thus decreasing noradrenergic transmission (Hunt et al.,
1976; Franklin and Herberg, 1977; Vetulani et al., 1977).
This suggestion is supported by other investigations (Wise
et al., 1973; Hastings and Stutz, 1943; Franklin and Herberg,
1974; German and Bowden, 1974; Belluzi et al., 1975; Shaw
and Rolls, 1976), which demonstrate that reduced noradrenergic transmission inhibits self-stimulation.

It must be

noted, however, that although inhibition of ICSS is reported
at doses which do not produce motor deficits the same doses
are reported to decrease locomotor activity when measured
in an activity chamber (Tilson et al., 1977).
4.

Conflict-induced Suppression
The Geller conflict procedure consists of a punish-

ment component and a non-punished component (Seiden and
Dykstra, 1977).

During the punishment component of this

procedure, punishment (usually an electric grid shock) is
superimposed on behavior (usually lever pressing for food
reward) whereas during the non-punished component no punishment is superimposed.
the punished component.

Behavior is usually reduced during
Anxiolytic drugs increase behavior

which has been suppressed by punishment (for review see
Seiden and Dykstra, 1977), and therefore the Geller conflict
procedure is widely used as a screening test for possible
anxiolytic agents.
Bullock et al.

(1978), reported that intraperitoneal

administration of clonidine (0.025-0.10 mg/Kg) in rats
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produced a significant increase in responding during the
punishment component of the Geller conflict procedure while
responding during the non-punished component was relatively
unaffected except at the highest dose (0.1 mg/Kg) where
sedation was observed.

These data suggest a possible anxio-

lytic action of clonidine.

C.

Aggressive Behavior
It has been suggested that central catecholamines and sero-

tonin are involved in the mediation of aggressive behavior
(for review see Seiden and Dykstra, 1977).
(1975) reported that clonidine (40 mg/Kg)

Ozawa et al.
induced aggres-

sive behavior in mice without altering the levels of brain
serotonin, norepinephrine or dopamine.

In contrast, how-

ever, Razzak et al., 1977 reported that a large dose of
clonidine, which induced automutilation in mice, markedly
increased brain norepinephrine; slightly increased brain
dopamine levels and did not change cerebral serotonin levels.
The results of these studies suggest further investigation
of the effect of clonidine on cerebral neurotransmitter
levels and their turnover in relationship to aggression
induced by this drug.
Morpurgo (1968)

first reported that intraperitoneal

administration of high doses (10 and 50 mg/Kg) of clonidine
induced aggression (biting attacks) in mice but not rats
nor rabbits.

This behavior was also produced when clonidine

was administered orally, intravenously or subcutaneously.
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Intracerebral injection of a 0.5% solution of clonidine
irmnediately elicited biting attacks (Morpurgo, 1968).
Other imidazoline derivatives (naphazoline, oxymetazoline), with similar peripheral sympathomimetic effects as
clonidine did not induce biting even when administered intracerebrally (Morpurgo, 1968).

This is particularly in-

teresting in view of the finding that the imidazoline derivatives, including naphazoline and oxymetazoline, which do
not cross the blood-brain barrier produce analgesia when
administered intracerebroventricularly (Schmitt et al.,
1974).
Pretreatment with neuroleptic drugs (e.g. haloperidol
ED 50 1.6 mg/Kg)

inhibited the occurrence of clonidine-in-

duced biting attacks.

However, pretreatment with the alpha-

adrenergic blocking agent, phentolamine, or the anti-cholinergic drug, atropine, were ineffective in preventing the
occurrence of aggressive behavior (Morpurgo, 1968). Since
the sympathomimetic effects of clonidine were still evident
following neuroleptic pretreatment, the findings of Morpurgo
(1968) suggested that clonidine-induced aggression in mice
is independent of its alpha-adrenergic action.
In contrast, however, Ozawa et al.

(1975) reported

that aggressive behavior in mice induced by intraperitoneal
administration of clonidine (40 mg/Kg) was markedly inhibited
by intraperitoneal pretreatment with the alpha-blocking
agent phenoxybenzamine (20 mg/Kg).

Similarly, Razzak et al.

(1977) reported that automutilation induced by a large dose
of clonidine was inhibited by reserpine, alpha-methyl-para32

tyrosine, phenoxybenzamine, phentolamine or chlorpromazine
pretreatment.
Pretreatment with amytriptyline, PCPA, L-dopa, 5-HTP
or glycine had no effect on the clonidine-induced aggression
and self-mutilation (Ozawa et al., 1975; Stern and Catovic,
1975; Razzak et al., 1977).
Aggression and automutilation induced by clonidine was
reported to be potentiated by disulfarim, lithium chloride
(Ozawa et al., 1975); nalorphine, mephenesin (Stern and
Catovic, 1975); methamphetamine, caffeine and theophylline
(Razzak et al., 1977).
These results suggest therefore, that central noradrenergic mechanisms are involved in the mediation of aggression
and automutilation induced by clonidine.
In rats aggression can be induced by sufficiently high
doses of the dopaminergic agonist, apomorphine (McKenzie,
1971) or by termination of chronic narcotic administration
(Lal, 1975).

It has been suggested that both of these forms

of aggression are due to hyperstimulation of dopaminergic
neurons in the central nervous system (Lal, 1975; Lal et al.,
1975).

Clonidine by itself at doses of 0.25 and 0.5 mg/Kg

administration subcutaneously did not produce aggression in
drug-naive rats; however it dose-dependently (0.0625-0.25
mg/Kg) enhanced aggression produced by a sub-threshold (for
aggression) dose (2.5 mg/Kg) of apomorphine and enhanced
aggression when administered to 72 hour morphine-withdrawn
rats (Gianutsos et al., 1976).
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It has also been reported that irritability and violent aggressive behavior occurs in rats following chronic
treatment with clonidine (Laverty and Taylor, 1969) and
that rats become irritable and aggressive while receiving
clonidine (5 ug/ml) in their drinking water (Dix and
Johnson, 19 77).
While all of the previously cited studies suggest that
clonidine may act to promote aggressive behavior in mice
and rats, Laverty and Taylor (1969) reported that subcutaneous administration of clonidine (0.2-1.0 mg/Kg) produced
a dose dependent inhibition of pain-induced aggressive behavior produced by application of electric shocks to the
grid floor of a cage in which a pair of rats were placed
and Cornfeldt et al.

(1978) reported that clonidine (ED50

3.8 mg/Kg p.o.) inhibited foot-shock induced aggression in
mice.

However, clonidine is known to produce analgesia

(see Analgesia section) as measured by an increase in the
threshold for vocalization (Paalzow, 1974; Schmitt et al.,
1974) and vocalization after discharge (Paalzow, 1974;
Paalzow and Paalzow, 1976) following electrical stimulation
of the rat's tail, and several other procedures.

There-

fore, clonidine-induced inhibition of pain-induced fighting
(produced by electrical shock application to the grid floor)
may be the result of its analgesic action and not the result of its ability to modulate aggressive behavior.
In conclusion it has been demonstrated that clonidine
may promote, inhibit or have no effect on aggressive behavior.
34

Clonidine's action on aggressive behavior appears to depend
on several factors including species, dose, treatment regimen (acute vs. chronic) and method of inducing aggression.
Aggressive behavior produced by clonidine appears to be dependent on both dopaminergic and noradrenergic brain

D.

mechanisms.

Drug Self-Administration
Drugs of several pharmacological classes are self-

administered for their positive reinforcing properties (for
review see Seiden and Dykstra, 1977).

Investigations of

the neurochemical basis of reinforcement resulting from the
self-administration of narcotics (Davis and Smith, 1972,
1973a; Glick et al., 1973) and psychomotor stimulants (Davis
and Smith, 1972, 1973b) have implicated the involvement of
central catecholaminergic systems (for review see Seiden
and Dykstra, 1977) .

Attempts to differentiate between nor-

adrenergic and dopaminergic mechanism suggest the involvement of noradrenergic mechanisms in opiate reinforcement
(Davis et al., 1975) while both dopaminergic and noradrenergic mechanisms appear to be involved in psychomotor
stimulant reinforcement (Davis et al., 1975; Davis and
Smith, 19 7 5) •
Bavis and Smith (1977) reported that clonidine (15
but not 1 ug/Kg/injection) was self-administered by rats
when this drug was made contingent on lever pressing.
w~s

It

suggested that the reinforcing action of clonidine was

the result of its stimulatory action at post-synaptic
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alpha-noradrenergic receptors since intraperitoneal pretreatment with the alpha-blocking agent phenoxybenzamine (15
mg/Kg) prevented the reinforcement associated with clonidine
administration (Davis and Smith, 1977).

Furthermore, intra-

peritoneal pretreatment with phenoxybenzamine (15 mg/Kg) but
not haloperidol (5 mg/Kg) prevented the establishment of a
stimulus paired with injections of clonidine as a conditioned
reinforcer (Davis and Smith, 1977).

These results suggest

that stimulation of alpha-noradrenergic receptors by clonidine results in positive reinforcement.
In rats self-administering the synthetic narcotic
fentanyl (1 ug/Kg injection), Shearman et al.

(1977) re-

ported that substitution of clonidine (15 but not 1 ug/Kg/
injection)

for the fentanyl solution maintained self-

administration behavior.

Since activation of noradrenergic

systems is considered to be involved in the mediation of
narcotic reinforcement (Davis, 1975), the maintenance of
f entanyl-reinforced responding by clonidine may be the result of its ability to stimulate central noradrenergic receptors.

E.

Drug Discrimination
It is now widely established that drugs of several

pharmacological classes can function as discriminative
stimuli (for review see Lal, 1977) •

Usually in these ex-

periments laboratory animals are trained to emit one response when treated with a drug and an alternate response
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when treated with the drug vehicle, another dose of the
same drug or a different drug.

When acquisition of such

response differentiation is reliably shown the drug is
said to produce a discriminative stimulus that controls
the differential responding in the trained subjects.
In rats trained to discriminate morphine (10 mg/Kg)
from saline, Miksic et al.

(in press) reported that intra-

peritoneal administration of clonidine (0.08-0.64 mg/Kg)
produced saline lever selection.

Since the discriminative

stimulus produced by morphine is considered to be related
to its subjective effect in man (Lal and Gianutsos, 1976;
Lal et al., 1977), this data suggests that clonidine and
morphine may produce dissimilar subjective effects.

In

view of the fact that clonidine produces analgesia (see
Analgesia section) and reduces narcotic withdrawal symptoms in animals and humans (see Antiwithdrawal section),
this data becomes particularly interesting for it suggests
that clonidine may provide a non-narcotic treatment for
opiate addiction.

F.

Learning and Memory
While an important role fur each of the central neuro-

transmitters in learning and memory processes has been postulated (for review see Seiden and Dykstra, 1977), the exact
role of each remains unclear.

Furthermore, studies measur-

ing the effect of pharmacological agents on learning and
memory processes must be interpreted with caution since
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factors unrelated to their effect on learning and memory
(i.e., sedation, impairment of motor function) can affect
'

the results.
Gazzani and Izqueirdo (1976) reported that post-trial
intraperitoneal administration of clonidine (O.l mg/Kg) or
haloperidol (0.5 mg/Kg) to rats trained in a shuttle avoidance paradigm resulted in a lower retention of this task in
a retest session carried out seven days later compared to
animals which received a post-trial saline injection.

This

effect of clonidine was prevented by pretreatment with
either phenoxybenzamine (10 mg/Kg) or phentolamine (10 mg/Kg)
whereas the effect of haloperidol was prevented by apomorphine (4 mg/Kg; but not 0.5 mg/Kg) pretreatment.

These data

suggest that clonidine may impair memory consolidation.
In contrast to the above study, however, McEntee and
Mair (1978) reported that administration of clonidine to
Korsakoff syndrome patients (who had low CSF MHPG levels
which correlated with memory impairment) resulted in a consistent improvement of memory function.

Since clonidine is

a presumed alpha-noradrenergic agonist in the central nervous
system, improvement of memory by clonidine (McEntee and Mair,
1978), provides additional evidence for an important role
of norepinephrine in learning and memory processes.

G.

Arousal Mechanisms
Investigations of the neurochemical mechanisms underly-

ing arousal processes suggest that involvement of both
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serotonin and catecholamines (for review see Seiden and
Dykstra, 1977).
Clonidine has been reported to produce sedation and
sleep when administered via several routes to young chicks,
rats, cats, rabbits and man (Zamis, 1970; Holman et al.,
1971; Florio et al., 1975; Marley and Nistico, 1975; Walland,
1977).

Given intravenously clonidine-induced sleep is in-

distinguishable from normal sleep or that elicited by intravenous noradrenaline or adrenaline (Holman et al., 1971).
Behavioral depression and EEG synchronization induced
by clonidine (0.1 mg/Kg) in rats, cats and rabbits were attenuated by pretreatment with the alpha-noradrenergic receptor blocking agents phentolamine (10 mg/Kg) , tolazoline
(10 mg/Kg) and yohimbine (0.5 mg/Kg) but not phenoxybenzamine (10 mg/Kg)
et al.
-

(Florio et al., 1975).

Similarly, Holman

(1971) and Delbarre and Schmitt (1971) noted that

the sedative effect of clonidine was antagonized by phentolamine.

Whereas pretreatment with the serotonin receptor

antagonist methysergide or the serotonin synthesis inhibitor
failed to prevent the sleep-inducing effect of clonidine,
LSD pretreatment effectively prevented the sleep-producing
effect of clonidine (Holman et al., 1971).

Pretreatment

with alpha-methyl-para-tyrosine ester· ( 100 mg/Kg, 3 days)
or reserpine (2 mg/Kg) potentiated the clonidine (0.1 mg/Kg)induced sedation and EEG synchronization (Florio et al.,
1975).
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Amphetamine (1 or 2 mg/Kg) reversed the behavioral depression and EEG synchronization produced by clonidine
(0.2 mg/Kg)

(Florio et al., 1975).

Furthermore, clonidine

abolished the behavioral activation and EEG desynchronization induced by amphetamine (Florio et al., 1975; Marley
and Nistico, 1975) and methamphetamine (Gogolak and Stumpf,
1969); however, the EEG arousal produced by physostigmine
was unaffected by clonidine (Gogolak and Stumpf, 1969).
Clonidine also increased the threshold of the EEG-arousal
reaction caused by reticular stimulation (Gogolak and Stumpf,
19 69) .
Behavioral and electrocortical sleep induced by intraventricular administration of clonidine (5-15 ug) was easily
interrupted by an arousing stimulus (Holman et al., 1971)
and presentation of sensory stimuli during clonidine-induced
sleep, induced behavioral and phasic electrocortical arousal
(Marley and Nistico, 1975).
In conclusion, several studies have demonstrated a
sedative or sleep-inducing action of clonidine.

These in-

vestigations suggest that the sleep-inducing effect of
clonidine occurs through a stimulatory action of this drug
at central alpha-noradrenergic receptors (Florio et al.,
1975; Marley and Nistico, 1975).

It does not appear that the

sleep-inducing action of clonidine depends on serotonergic
transmission (Holman et al., 1971).
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H.

Analgesia
Investigations of the neurochemical mechanisms underly-

ing the perception of painful stimuli suggest the involvement of serotonin, and catecholamines and possibly other
neurotransmitters (for review see Seiden and Dykstra, 1977).
Furthermore, data suggests that serotonin and catecholamines
are involved in the mediation of narcotic analgesia (for
review see Seiden and Dykstra, 1977).
The antinociceptive activity of clonidine has been
demonstrated in a variety of procedures believed to induce
pain in laboratory animals including electrical stimulation
of the tail; Charpentier's test (Paalzow, 1974; Paalzow and
Paalzow, 1976; Schmitt et al., 1974), placing the animal on
a hot (560C) plate; hot-plate test (Schmitt et al., 1974),
immersion of the tail in hot (55°c) water; tail withdrawal
test (Sewell and Spencer, 1975; Fielding et al., 1977, in
press), exposure of the tail to radiant heat; tail flick
test (Fielding et al., 1977, 1978), applicationofpressure
to an inflamed paw; Randall-Selitto test (Fielding et al.,
1977, in press) and intraperitoneal injection of phenylp-benzoquinone (Fielding et al., 1977, in press), acetic
acid or acetylcholine; writhing tests (Bentley et al., 1977).
Furthermore, in all of the above procedures (except the tail
withdrawal test in rats, Fielding et al., 1977, in press)
clonidine was found to be more potent than morphine.
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1.

Charpentier's Test
Paalzow (1974) measured the changes in the threshold

for vocalization in mice and the threshold for motor response (spinal reflex), vocalization and vocalization after
discharge in mice and rats produced by electrical stimulation of the tail.

Subcutaneous administration of clonidine

(0.08-1.25 mg/Kg) produced a dose-dependent increase (100500%) of the threshold for vocalization and vocalization
after discharge in rats while the threshold for motor response was unaffected (Paalzow, 1974).

The threshold for

a motor response was raised 100% at a dose of 10 mg/Kg,
however, this dose produced sedation and marked sympathometic signs (Paalzow, 1974). Clonidine also increased the
threshold for vocalization in mice; however, the dose was
higher (2.5-10.0 .1mg/Kg)

than that

required to produce a

similar elevation in rats (Paalzow, 1974).
Chlorpromazine (5 mg/Kg, s.c.), atropine (1 mg/Kg,
s.c.) and p-chlorophenylalanine (400 mg/Kg, i.p.) pretreatment increased the antinociceptive activity of clonidine
(0.625 mg/Kg, s.c.) at both the threshold for vocalization
and vocalization after discharge while phenoxybenzamine
(10 mg/Kg, i.p.) and reserpine (10 mg/Kg, i.p.) pretreatment increased the activity at the threshold for vocalization only leaving the threshold for vocalization after
discharge unaffected (Paalzow and Paalzow, 1976).

Yohimbine

(2 mg/Kg, i.p.) pretreatment decreased the antinociceptive
activity of clonidine at both thresholds while 5-hydroxy42

tryptophan (50 mg/Kg, i.p.) and alpha-methyl-para-p-tyrosine
(250 mg/Kg, i.p.) pretreatment decreased the effects at the
threshold for vocalization after discharge only (Paalzow
and Paalzow, 1976).

Naloxone (8 mg/Kg, s.c.) pretreatment

or concomitant LSD (50 ug/Kg, s.c.) did not alter the antinociceptive activity of clonidine at either pain response
studied (Paalzow and Paalzow, 1976).
Schmitt et al.

(1974) reported the effect of clonidine

on four types of behavioral reactions to the electrical
stimulation of the rat's tail:

startle, flight, vocaliza-

tion and biting of the electrodes.

Intraperitoneal adrninis-

tration of clonidine (0.5-3 mg/Kg) produced a dose-dependent
reduction on the startle, the cry and the biting of electrodes; however, clonidine was weakly effective on flight
(Schmitt et al., 1974).
clonidine (30 ug)

Intraventricular administration of

reduced the startle and the biting of

electrodes but was less effective on the startle and on the
flight (Schmitt et al., 1974).

Intraventricular adrninistra-

tion of clonidine was 5-7 times as potent as clonidine administered intraperitoneally (Schmitt et al., 1974).
2.

Hot Plate Test
The hot plate test measures the ability of drugs to

inhibit reflex responses of mice placed on a hot place
maintained at a constant temperature between 55° and 70° C
(Seiden and Dykstra, 1977).

A drug is said to produce

analgesia when the reaction time to the heat is significantly
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increased.

Schmitt et al.

(1974) reported that intraperi-

toneal (O.l and 1.0 mg/Kg) and intraventricular (.3-1 ug)
administration of clonidine increased the reaction time to
heat.

The antinociceptive activity of clonidine in

Charpentier's and the hot plate test appears to be mediated centrally, since other alpha-sympathomimetics of the
imidazoline series (naphazoline, tetryzoline and oxymetazoline) which do not cross the blood-brain barrier possess
antinociceptive action only when administered intracerebroventricularly (Schmitt et al., 1974).
3.

Tail Withdrawal Test
The tail withdrawal test measures the ability of

drugs to alter the amount of time required of mice or rats
to withdraw their tail from hot water usually maintained at
55°c.

A drug is said to produce analgesia in this test if

the time required for tail withdrawal is significantly increased.
Using the tail-withdrawal test in mice, Sewell and
Spencer (1975) reported that subcutaneous administration of
clonidine (0.3 mg/Kg) produced analgesia.

However, when

clonidine (0.5 mg) was injected intracerebroventricularly
it possessed only marginal antinociceptive activity and
furthermore substantially reduced the analgesic action of
morphine (3 mg/Kg, s.c.) when given concurrently (Sewell
and Spencer, 1975).

The antinociceptive activity of sub-

cutaneously administered clonidine (0.3 mg/Kg) was significantly antagonized by concurrent intraventricular
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administration of phentolamine (5 mg) while the antinociceptive activity of subcutaneously administered morphine
(3 mg/Kg) and pentazocine (15 mg/Kg) was significantly potentiated by intraventricular injection of phentolamine
(10 ug)

(Sewell and Spencer, 1975).

Intraventricular ad-

ministration of propranolol (10 ug) did not potentiate the
antinociceptive activity of concurrent administration of
subcutaneous doses of morphine (2.5 mg/Kg), pentazocine
(15 mg/Kg) or clonidine (0.3 mg/Kg)

(Sewell and Spencer,

19 7 5) •
Intraperitoneal administration of clonidine (2.5 and
10.0 mg/Kg) in rats was effective in inhibiting tail-withdrawal from hot water (Fielding et al., 1977, in press).
Naloxone (5 mg/Kg) did not antagonize the antinociceptive
action of clonidine (2.5 mg/Kg)

(Fielding et al., 1977,

in press).

4.

Tail Flick Test
The tail flick test measures the ability of drugs

to alter the time required of mice or rats to remove their
tails from a radiant heat source.

A drug is considered to

produce analgesia in this test if the time required for
removal of the tail from the heat is significantly increased.
Subcutaneous administration of clonidine was reported
to produce a dose-dependent (ED 50 0.7 mg/Kg) inhibition of
the tail flick response inmice (Fielding et al., 1977, 1978).
The antinociceptive action of clonidine in this test was not
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antagonized by naloxone (1.0 mg/Kg)

(Fielding et al., 1977,

1978) or phenoxybenzamine (10.0 mg/Kg)

(Fielding et al.,

in press).
Subcutaneous administration of clonidine (0.016 mg/Kg)
potentiated the analgesic activity of :roo.rphine in the tail
flick test approximately 5-fold while morphine (0.16 mg/Kg)
potentiated the antinociceptive action of clonidine 4-fold
(Spaulding et al., 1978).

Naloxone reversed the enhanced

effect of clonidine by morphine (Spaulding

et al., 1978).

Tolerance to the antinociceptive action of clonidine
in the tail-withdrawal and tail flick procedures was not
observed (Fielding et al., 1977). Furthermore, cross-tolerance to the antinociceptive action of clonidine in morphinepelleted mice was not observed (Spaulding et al., 1978).

5.

Randall-Selitto Test
The Randall-Selitto test measures the ability of

drugs to alter the reaction to pressure applied to an inf;Lamed paw by an "analgesia . meter." A drug is considered
to produce analgesia in this procedure when the amount of
pressure required to induce a reaction is significantly increased.
In a modified version of the Randall-Selitto test,
Fielding et al.

(1977, in press) reported that subcutaneous

administration of clonidine (0.125-1.0 mg/Kg) produced a
dose-dependent increase in the threshold to pain produced
by pressure on an inflamed paw.
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6.

Writhing Tests
Writhing tests measure the ability of drugs to al-

ter writhing induced by other chemical agents.

A drug is

considered to produce analgesia in this test when the number
of writhes induced by the chemical agent is significantly
decreased.
Subcutaneous administration of clonidine (0.0125-0.05
mg/Kg) into mice produced a dose-dependent inhibition of
writhing induced by phenyl-p-benzoquinone (Fielding et al.,
1977, in press).

The anti-writhing action of clonidine was

not antagonized by naloxone (1.0 mg/Kg)

(Fielding et al.,

1977, in press) or phenoxybenzamine (Fielding et al., 1977).
Clonidine, oxymetazoline and 1-noradrenaline bitartarate were equi-effective in antagonizing the nociceptive action of acetic acid or acetylcholine when administered subcutaneously in mice while phenylephrine was ineffective
(Bentley et al., 1977).

Clonidine was the most potent

antagonist (Bentley et al., 1977).

Piperoxane (8 and 16

mg/Kg) antagonized the antinociceptive action of oxymetazoline and noradrenaline and partially antagonized the antinociceptive effect of clonidine while phentolamine (16 mg/Kg)
had no antagonistic effect on any of the three drugs
(Bentley et al., 1977).

Clonidine and oxymetazoline were

more potent when administered intracisternally; however,
their antinociceptive action when administered by this route
was not antagonized by piperoxane (16 mg/Kg) administered
subcutaneously or (50 ug/Kg) intracisternally (Bentley et
al., 1977).

In sununary, these investigations demonstrate that clonidine produces a dose-dependent analgesia as measured by a
variety of procedures considered to induce pain in laboratory
animals.

Clonidine-induced analgesia does not seem to be

the result of an impairment of motor function since the
threshold for a motor response (Paalzow, 1974) or flight
reaction (Schmitt et al., 1974) is unaffected at doses which
produce analgesia.

The analgesic action of clonidine ap-

pears to be mediated centrally since other alpha-sympathomimetics of the imidazoline series which do not cross the
blood-brain barrier possess antinociceptive activity only
when administered intracerebroventricularly (Schmitt et al.,
1974).

However, the antinociceptive action of clonidine in

writhing tests may be due to its stimulatory action on
alpha-adrenoceptors located on sensory nerve endings in the
peritoneum since other peripherally acting alpha-agonists
are also antinocicpetive in these tests (Bentley et al.,
1977).

Depending on the dose, route of administration and

species, i t appears that clonidine may increase (Spaulding
et al., 1978) or decrease (Sewell and Spencer, 1975) the
analgesic action of morphine.

However, unlike narcotics

tolerance to the antinociceptive action of clonidine is
not observed (Fielding et al., 1977) nor is cross-tolerance
observed in morphine-dependent mice (Spaulding et al.,
1978).

The lack of naloxone antagonism of the antinocicep-

tive action of clonidine (Paalzow and Paalzow, 1976;
Fielding et al., 1977, 1978) suggests that the analgesic
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action of clonidine is not mediated through an interaction
with opiate receptors.

Based on the results of studies in-

vestigating the effect of other drugs on clonidine-induced
analgesia (Paalzow and Paalzow, 1976; Sewell and Spencer,
1975; Fielding et al., 1977, 1978; Bentley et al., 1977)
it appears that several neurochemical systems may mediate
the antinociceptive action of clonidine.

I.

Antiwithdrawal
Recently, Redmond et al.

(1976) and Redmond (1977) re-

ported that the effects of electrical or pharmacological
activation of the locus coeruleus in monkeys were strikingly similar to those noted during opiate withdrawal.

Thus

i t was suggested that the symptoms of opiate withdrawal were
the result of excess noradrenergic activity within the locus
coeruleus (Redmond, 1977).
Fielding et al.

(1977; in press) reported that cloni-

dine (0.01-0.16 mg/Kg) decreased morphine withdrawal wet
shakes when intraperitoneally administered to morphinedependent rats during withdrawal produced by discontinuation
of morphine administration.

Similarly, Tseng et al.

(1975)

and Vetulani and Bednarczyk (1977) reported that clonidine
(0.1-0.8 mg/Kg) decreased wet shakes produced by administration of narcotic antagonists in morphine-dependent rats.
Furthermore, clonidine (5 ug/Kg) has been reported to eliminate opiate withdrawal signs in narcotic addicts undergoing
voluntary detoxification (Gold et al., 1978; Washton, et
al., 1978).
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The ability of clonidine to decrease narcotic withdrawal does not seem to be mediated through a drug action at
opiate receptors.

Naloxone did not antagonize the ability

of clonidine to decrease wet shakes in rats (Fielding et al.,
in press) nor did naloxone precipitate withdrawal in a
clonidine-maintained opiate-free individual or block the
decrease in opiate withdrawal symptoms in humans (Washton
et al., 1978).

Because opiate withdrawal symptoms have been

suggested to be the result of excessive noradrenergic activity within the locus coeruleus (Redmond, 1977), the ability of clonidine to reduce opiate withdrawal symptoms may
be the result of its stimulatory action at presynaptic alphanoradrenergic receptors of the locus coeruleus thus decreasing noradrenergic activity.

This suggestion is supported

by the finding that the opiate withdrawal-like symptoms
produced by electrical or pharmacological activation of the
locus coeruleus are blocked by clonidine (Redmond, 1977).
Clonidine has also been reported to decrease the
sweating, tremor and anxiety associated with alcohol withdrawal in humans (Bjorkqvist, 1975).
In conclusion, studies of the effect of clonidine in
the treatment of narcotic and alcohol withdrawal suggest
that clonidine may provide a non-opiate treatment for narcotic withdrawal (Washton et al., 1978) and may be useful
in the treatment of other drug withdrawal states associated with anxiety and increased noradrenergic activity.

so

J.

Food and Water Consumption
Investigations of the neurochemical mechanisms under-

lying feeding and drinking behavior suggest that alphanoradrenergic mechanisms may elicit these behaviors (for
review see Seiden and Dykstra, 1977). In dogs, clonidine
increased food intake at low doses and reduced i t at high
doses (Le Douarec et al., 1972).

In rats clonidine re-

duced food intake (Le Douarec et al., 1972).

Piperoxane

antagonized the inhibitory effect of clonidine on food intake in rats while yohimbine and phentolamine provided
partial antagonism.

However, many alpha-adrenergic recep-

tor blockers such as tolazoline, dibenamine and phenoxybenzamine were ineffective as were beta-adrenergic receptor
blockers (Le Douarec et al., 1972).
Intrahypothalamic injection of clonidine increased
food intake in satiated rats (Le Douarec et al., 1972).
Similarly, Holman et al.

(1971) reported that following in-

traventricular administration of clonidine (25-75 ug/Kg)
in rats approximately one-third of the rats began eating
continuously and sometimes periods of eating alternated
with periods of sleep.
In an investigation of the effect of clonidine on behavior associated with food intake, Poignant and Rismondo
(1975) reported that clonidine (0.05-0.2 mg/Kg) increased
the take-up time of a standard alimentary material in hamsters without affecting the associted hoarding behavior.
In contrast, amphetamine (1 and 2 mg/Kg) modified both
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take-up time and hoarding behavior (Poignant and Rismondo,
19 7 5) .
Clonidine reduced water intake and induced diuresis
in rats given the opportunity to drink water after 18 hours
of water deprivation (Le Douarec et al., 1971).

The reduc-

tion in water intake was antagonized by piperoxane, tolazoline and phentolamine; however, other alpha-adrenergic receptor blockers such as dibenamine and phenoxybenzamine were
ineffective (Le Douarec et al., 1971).

Beta-adrenergic

blockers as well as the cholinergic drugs atropine and mecamyline were devoid of any antagonistic activity (Le Douarec
et al., 1971).
In conclusion, clonidine may increase or decrease food
intake depending on the dose, species, route of administration and food deprivation state of the animal (Le Douarec
et al., 1972).

However, clonidine's effect on water intake

seems to be solely inhibitory (Le Douarec et al., 1971).
Feeding elicited by intrahypothalamic (especially the perifornical area) injection of norepinephrine in sated rats
is blocked by the administration of alpha-noradrenergic
receptor blockers (for review see Seiden and Dykstra, 1977),
therefore clonidine's action to increase food intake in
satiated rats may be the result of its stimulatory action
at post-synaptic, alpha-receptors.

However, because of

the differential antagonism of the clonidine-induced decrease
in food and water intake by alpha-adrenergic blocking
agents, i t appears that the receptors involved in mediating
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these inhibitory effects ofclonidine have some properties
in common with classical alpha-adrenergic receptors but
are different in some way (Le Douarec et al., 1971, 1972).
Since intrahypothalamic administration of norepinephrine in sated monkeys is reported to elicit drinking
(Myers, 1969), the clonidine-induced decrease in the water
intake of water deprived rats may be related to a stimulatory action of clonidine at pre-synaptic alpha-adrenergic
receptors, thus decreasing noradrenergic transmission.
However, it may be that clonidine's action on water intake
depends on the water deprivation state (i.e. sated or deprived) of the subject.

K.

Body Temperature
Thermoregulation normally involves the integration of

both behavioral and physiological mechanisms.

Investiga-

tions of the role of central neurotransmitters in thermoregulation suggests the involvement of both catecholamines and
serotonin (Stricker and Zigmond, 1976; Cooper et al., 1978).
Wendt and Caspers (1968) reported a suppression of
sweating in man during heat exposure and exercise after
oral administration of 75 and 150 ug (about 1 and 2 ug/Kg)
clonidine, while Laverty and Taylor (1969) observed a fall
in body temperature when clonidine (0.1-2.5 mg/Kg) was administered subcutaneously into rats.

Similarly, Tsoucaris-

Kupfer and Schmitt (1972) found that subcutaneous or intraperitoneal administration of clonidine (0.5-1.5 mg/Kg)
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induced hypothermia in rats, the intensity and duration of
which was dose-dependent.
clonidine (15 ug)

Intraventricular injection of

(Tseng et al., 1975), but not (2-3 ug)

(Tsoucaris-Kupfer and Schmitt, 1972) lowered body temperature in rats and produced a dose-dependent (0.02-0.2 urnol)
hypothermia in young chicks (Marley and Nistico, 1975).
Intrahypothalamic administration of clonidine (3 ug or
0.04 urnol) is also reported to produce hypothermia
(Tsoucaris-Kupfer and Schmitt, 1972; Marley and Nistico,
1975).
The hypothermia produced by the various routes of clonidine administration was antagonized by the alpha-blocking
agents phentolamine, phenoxybenzarnine, piperoxane, tolazoline and dibenarnine (Tsoucaris-Kupfer and Schmitt, 1972;
Reid et al., 1975; Marley and Nistico, 1975).

Piperoxane

was the most effective antagonist (Tsoucaris-Kupfer and
Schmitt, 1972).

The beta-adrenergic receptor antagonists,

propranolol, pindolol and Ko 1366 were also reported to be
effective in decreasing the hypothermic effect of clonidine
(Tsoucaris-Kupfer and Schmitt, 1972).
al.

However, Reid et

(1975) and Marley and Nistico (1975) reported that pro-

pranolol did not alter the hypotherrnic action of clonidine.
Similarly, Tsoucaris-Kupfer and Schmitt (19722), reported
that atropine and haloperidol were effective in decreasing
the hypotherrnic effect of clonidine while mecamyline and
imipramine were ineffective.

However, Maj et al.. ( 19 7 5)

and Marley and Nistico (1975) reported that atropine did
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not affect clonidine-induced hypothermia and Reid et al.
(1975) reported that the relatively selective dopamine receptors antagonist did not alter the hypothermic effect of
clonidine.

Furthermore, Marley and Nistico (1975) reported

that haloperidol did not attenuate the hypothermic effect
of clonidine.

Other alpha-sympathomimetic imidazolines

such as naphazoline, tetryzoline and oxymetazoline, which
do not cross the blood-brain barrier (Walland, 1977); were
also effective in producing hypothermia after peripheral
~dministration

(Tsoucaris-Kupfer and Schmitt, 1972).

Fur-

thermore, depletion of brain catecholamines by intracisternal administration of 6-0HDA failed to alter the hypothermic
I

response to clonidine (Reid et al., 1975).

Therefore, the

hypothermic effect of clonidine may be due to an action at
both central and peripheral sites.
Scheel-Kruger and Hasselager (1974) reported that the
hypothermia induced by clonidine (0.5 mg/Kg)

in rats could

be antagonized by apomorphine (2 x 2.5 mg/Kg).

It was sug-

gested that the hypothermic effect of clonidine was due to
its action on serotonin turnover since apomorphine also
produced a significant antagonism of the clonidine-induced
decrease of 5-hydroxy-indole acetic acid levels, the time
course of which correlated with its antagonism of clonidineinduced hypothermia (Scheel-Kruger and Hasselager, 1974).
However, Marley and Nistico (1975) reported that intraventricular pretreatment with the serotonin receptor blocker,
methysergide

(0.1 umol) did not attenuate the hypothermic
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effect produced by intraventricular injection of clonidine
(0.05-0.2 umol).
Finally, Tseng et al.

(1975) reported that intraperi-

toneal (0.1-0.4 mg/Kg) or intraventricular (5 and 15 ug)
administration of clonidine inhibited precipitated shakes
and potentiated escape attempts induced by naloxone in
morphine-dependent rats.

These forms of morphine-withdrawal

were previously suggested (Wei et al., 1974) to be related
to heat gain and heat loss mechanisms, respectively.
In conclusion, these findings demonstrate that clonidine produces hypothermia via several routes of administration.

Because of the antagonism of clonidine-induced hypo-

thermia by alpha-adrenergic blocking agents it appears that
the hypothermic action of clonidine is mediated by its
stimulatory action at alpha-adrenergic receptors.

This is

supported by the finding that hypothermia induced by intraventricular administration of norepinephrine is antagonized
by phentolamine (Burks, 1972).

However, as suggested by

Scheel-Kruger and Hasselager (1974)

the hypothermic effect

of clonidine may be secondary to its action on noradrenergic receptors and may be the result of the clonidine-induced
decrease in serotonin turnover (Anden et al., 1970; ScheelKruger and Hasselager, 1974; Rochette and Bralet, 1975).
Feldberg (1964) reported that intraventricular administration of serotonin produces hyperthermia, therefore it would
follow that a reduction in serotonin turnover produced by
clonidine would produce hypothermia.
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Finally, it cannot be

stated with certainty whether or not the hypothermic action
of clonidine occurs at central or peripheral alpha-adrenergic receptors or both, since other imidazoline sympathomimetics which do not cross the blood-brain barrier also
produce hypothermia when administered peripherally.

L.

Conclusion
In addition to its action on the noradrenergic system

clonidine has also been reported to affect other central
neurotransmitter systems.

Similarly, in addition to its

antihypertensive action, clonidine is reported to produce
several other pharmacological effects.
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METHODS
Subjects
The subjects were drug-naive male hooded rats of the
Long-Evans strain (Charles River Breeding Laboratories,
Wilmington, Mass.) weighing between 300-400 grams at the
beginning of the investigation.

Throughout the experiment

the subjects were given continuous access to food and water.
The animals were surgically prepared with chronic intravenous (jugular) catheters according to the method of Smith
and Davis (1975) with the following modifications:
um pentobarbital was used as the anesthetic; 2)

1) sodi-

the cannula

was constructed from PE 50 tubing; 3) nitrofurazone powder
was not applied to muscle before suturing together.
Surgical Procedure
Subjects were anesthetized with sodium pentobarbital
(50 mg/Kg) administered intraperitoneally.

On the ventral

surface the fur was shaved from the upper chest and lower
neck and on the dorsal surface from the back of the neck
just behind the ears.

Gauze soaked in a 95% ethanol solu-

tion was used to cleanse these areas.

With the animals in

a supine position a skin incision (approximately 2 cm in
length), which extended from the upper chest toward the
lower neck was made with a scalpel on the right side of
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the animal above the jugular vein.

Utilizing blunt dis-

section technique the underlying chest muscles were separated until the right jugular vein was exposed.

The vein

was then isolated (using needlepoint tweezers) by carefully removing the fat and connective tissue surrounding
it.

A trocar was placed under the vein to keep it isolated.

sterile surgical silk (Ethicon 000 Silk; Ethicon Inc.,
Somerville, N.J.) was tied in a loose knot around the vein
as far caudad as possible.

Using needlenose scissors, an

incision was made halfway through the vein.
(polyethylene 50 (PESO)) tubing;

A catheter

(Clay Adams, Parsipanny,

N.J.) filled with physiological saline was inserted into
the lumen of vein for 1/2" of its length. The silk was immediately tied tightly around the vein and cannula. Silk
was tied a second time around the vein and cannula just
cephalad to the first tie.

Saline (approximately .2 ml)

was administered through the catheter into the vein to
compensate for any blood loss and to check for leaks.
The cannula was considered to be in the vein when blood
could be withdrawn as the plunger was pulled back.

Using

hollow metal tubing, pointed at one end, the catheter was
passed subcutaneously under the right forelimb and out
through the shaved area on the dorsal surface of the neck.
The catheter was further secured by tying it (with Ethicon
000 Silk) to underlying muscle at two other points, thus
forming a triangle with the first ties.

Sterile surgical

gut (Ethicon 5-0 Chromic) was used to suture the overlying
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muscle together.

Finally, sterile srugical silk was used

to close the skin incision.

CombioticR (60,000 units;

Pfizer, New York, N.Y.) was injected intramuscularly into
a hind leg to give protection against possible infection.
Animals were subsequently placed in velcro harnesses so
that a saddle was strapped behind their forelegs.

The

catheter was passed through the harness and through a protective metal coil attached to the harness.

Subjects were

allowed 24 hours to recover from this surgical procedure
before being placed in the self-administration apparatus.

Apparatus
The self-administration apparatus consisted of conventional plexiglass operant chambers 26 x 20 cm and 26 cm
high enclosed in lightproof, ventilated, sound-attenuating
chambers.

The outer chambers contained a houselight turned

on between 8:00 A.M. and 8:00 P.M.

A response lever 4 cm

wide extended 3 cm into the operant chambers 3.5 cm above
the floor in the center of the short wall.

As the catheter

emerged from the protective metal coil i t passed through
the roof of the operant chamber and through the roof of the
outer chamber to where it was eventually connected to a
pneumatic driven Hamilton Precision Liquid Dispenser (PLD)
syringe (Hamilton Co., Reno, Nevada) located on top of the
outer chamber.

Depression of the response lever (weight

required 15 grams) activated the PLD syringe to deliver a
constant volume (100 ul/Kg) of a drug solution in less
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than one second into the jugular vein of the subject via
the catheter.

All programming and response recording was

performed utilizing electromechanical equipment (Lehigh
Valley Electronics, Lehigh Valley, Pa.).

Each day at the

same time the number of lever presses was recorded.

Drugs
Clonidine hydrochloride (Boehringer Ingelheim Ltd.,
Ridgefield, Ct.), fentanyl citrate (McNeil Laboratories,
Inc., Fort Washington, Pa.), and naloxone hydrochloride
(Endo Laboratories, Inc., Garden City, N.Y.) were dissolved in 0.9% sodium chloride.

Haloperidol, azaperone

and aceperone (Janssen Pharmaceutica N.V., Beerse, Belgium)
were dissolved in 0.3% tartaric acid.

Experimental Design
A total of 90 rats were used in this investigation.
Three rats were allowed to self-administer fentanyl (0.1
ug/Kg/injection) while 46 rats were allowed to self-administer fentanyl at a dose of 1 ug/Kg/injection. Thirtyeigh t rats were allowed to self-administer clonidine
(15 ug/Kg/injection) whereas three rats were allowed to
self-administer saline.

All solutions were self-adminis-

tered on a continuous reinforcement (CRF) schedule.
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A.

Fentanyl Self-Administration
1.

Effect of Increasing the Fentanyl Dose Per Injection
When, after four days of self-administration, lever

pressing rates of three rats allowed to self-administer
fentanyl (0.1 ug/Kg/injection) did not differ from lever
pressing rates of rats allowed to self-administer saline,
the fentanyl dose was increased to 1 ug/Kg/injection.

The

effect of increasing the fentanyl dose on self-administration
behavior was measured by comparing the response rates at
each dose of fentanyl.
2.

Effect of Clonidine and Saline Substitution for the

Fentanyl Solution
Twenty-one of the 46 rats allowed to self-administer
fentanyl (1 ug/Kg/injection) did not receive any other
treatment.

However, for four of the 46 rats allowed to self-

administer fentanyl (1 ug/Kg/injection), clonidine (15 ug/Kg/
injection) was substituted for the fentanyl solution when
a stable rate of fentanyl-reinforced responding was achieved.
A stable rate of fentanyl-reinforced responding was considered to have been achieved when the number of lever
presses to obtain fentanyl injections for each rat on two
consecutive days was within 20% of the mean number of lever
presses for those two days.

Similarly, for two out of the

46 rats, clonidine (1 ug/Kg/injection) was substituted for
fentanyl and for three out of the 46 rats saline was substituted.

Following substitution, subjects were allowed to
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self-administer clonidine or saline for four consecutive
days.

The effect of substituting clonidine and saline for

the fentanyl solution was measured by comparing the rate
of self-administration following clonidine and saline substitution to the rate of fentanyl self-administration before substitution.

3.

Effect of Adding Various Drugs to the Fentanyl Solu-

tion for Self-Administration of the Drug Mixture
For the remaining 16 of the 46 rats allowed to selfadminister (1 ug/Kg/injection), three different butyrophenones and naloxone were added to the fentanyl solution
when a stable rate of fentanyl-reinforced responding was
achieved.

A stable rate of fentanyl-reinforced responding

was considered to have been achieved when the number of
lever presses to obtain fentanyl injections for each rat
on two consecutive days was within 10% of the mean number
of lever presses for those two days.

Naloxone (N=3),

haloperidol (N=4), aceperone (N=S) or azaperone (N=4) were
added to the fentanyl solution for self-administration of
the drug mixture so that the subjects received 64 ug/Kg/
injection.

Each drug remained in the fentanyl solution

for two or three consecutive days.

Thereafter, the drugs

were removed from the fentanyl solution and the subjects
were allowed to self-administer fentanyl alone.

The effect

of the response contingent drug injections on fentanylreinforced responding was measured by comparing the number
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of lever presses to obtain the drug mixture with the number
of lever presses for fentanyl alone before adding the drugs
to the fentanyl solution.

The number of lever presses for

the drug mixture were expressed as a percentage of the mean
number of lever presses for f entanyl alone for the two days
before adding the drugs.

The effect of the response-contin-

gent drug injections on fentanyl-reinf.orced responding was
considered significant if, utilizing Scheffe's Test, p
B.

LO.OS.

Clonidine Self-Administration
1.

Effect of Increasing the Fixed-Ratio Requirement
Twenty-two out of 38 rats allowed to self-administer

clonidine (15 ug/Kg/injection) did not receive any other
treatment.

However, in one rat allowed to self-administer

clonidine on a CRF schedule the response requirement to obtain each clonidine injection was progressively increased
to a FR-3 and then to a FR-10 schedule of clonidine reinforcement.

The response requirement was increased when the

number of lever presses to obtain clonidine injections on
the CRF schedule was within 10% of the mean for those three
days.

The subject was allowed to self-administer clonidine

at each FR schedule for three consecutive days.

The effect

of increasing the response requirement on clonidine-reinforced responding was measured by comparing the number of
lever presses to obtain clonidine-injections at each FRrequirement and also by comparing the total amount of clonidine intake at each FR requirement.

64

Assuming independence

of the data the effect of increasing the FR requirement on
the above measures was considered significant if, utilizing
Tukey' s Test, p = c:: 0. 05.
2.

Effect of Adding Various Drugs to the Clonidine Solu-

tion for Self-Administration of the Drug Mixture
For the remaining 15 of the 38 rats allowed to selfadminister clonidine (15 ug/Kg/injection), naloxone or three
different butyrophenones were added to the clonidine solution
when a stable rate of clonidine-reinforced responding was
achieved.

A stable rate of clonidine-reinforced responding

was considered to have been achieved when the number of lever
presses to obtain clonidine injections for each rat on two
consecutive days was within 10% of the mean number of lever
presses for those two days.

Naloxone (N=3), haloperidol

(N=7) , aceperone (N=3) or azaperone (N=3) were added to the
clonidine solution so that the subjects received 64 ug/Kg/
injection.

Each drug remained mixed with the clonidine solu-

tion for self-administration of the drug mixture for three
consecutive days.

Thereafter, the drugs were removed from

the clonidine solution and subjects were allowed to selfadminister clonidine (15 ug/Kg/injection) alone.

The effect

of the response-contingent drug injections on clonidine-reinforced responding was measured as described for the effect
of these drugs on fentanyl-reinforced responding.

Similarly,

the effect of the respone contingent drug injections was
considered significant if, utilizing Scheffe's Test, p =<0.05.
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RESULTS
Acquisition of Fentanyl Self-Administration
As shown in Figure 1, subjects readily began to selfadminister fentanyl (1 ug/Kg/injection) when an intravenous
injection of this drug was made contingent on lever pressing on a continuous reinforcement (CRF) schedule.

From

day 1 to day 5 there was a gradual increase (m=74.5) in
lever pressing to obtain fentanyl injections, thereafter
the rate of self-administration stabilized.

It is also

shown that rats do not self-administer a lower dose (0.1
ug/Kg/injection) of fentanyl nor saline when their intravenous delivery is made contingent on a CRF schedule. Selfadministration rates of the latter (Figure 1) reflect lever
pressing produced by random locomotor activity.
In rats previously allowed to self-administer fentanyl
(0.1 ug/Kg/injection) on a CRF schedule, the substitution
of a higher dose (1 ug/Kg/injection) of fentanyl to be delivered on a CRF schedule promoted self-administration behavior (Figure 2).

On the fourth day of substitution (day

8) self-administration rates similar to those on day 4 of
drug-naive animals (Figure 1) were observed [252 + 73(3) vs.
239 + 49 (21)].
Acquisition of Clonidine Self-Administration
As shown in Figure 3, subjects readily began to selfadminister clonidine (15 ug/Kg/injection) when an intravenous
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Figure 1. Acquisition of fentanyl self-administration
in drug-naive rats when fentanyl (1 ug/Kg/injection)
was delivered on a continuous reinforcement (CRF)
schedule. Lack of acquisition of self-administration
when 0.1 ug/Kg/inj fentanyl or saline (N=3) was delivered on a CRF schedule. Each value represents the
mean + S.E. number of lever presses for the number
of subjects indicated in parantheses.
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injection of this drug was made contingent on lever pressing.
An increase (m=49.9) in lever pressing to obtain clonidine
injections was observed from day 1 to day 3, thereafter selfadministration rates stabilized.

Five out of the 23 sub-

jects that began to self-administer clonidine died.

The

mean number of lever presses for lethality of these subjects
was 108 + 12.

Effect of Increasing the Fixed Ratio Requirement on Lever
Pressing to Obtain Clonidine Injections
When the fixed ratio (FR) requirement to obtain each
clonidine injection was increased from FR-1 to FR-3 a small
but significant (p< .05; Tukey Test) increase in lever
pressing to obtain clonidine injections was observed (Figure
4).

However, total daily clonidine intake (Table 1) at

the FR-3 schedule was decreased significantly (p< .05; Tukey
Test) from the FR-1 schedule.

On the other hand, when the

the FR requirement was increased from FR-3 to FR-10 a significant increase (p'- .01, Tukey Test) in lever pressing
(Figure 4)

to obtain clonidine injections was observed such

that total daily clonidine intake at the FR-3 and FR-10
schedules of clonidine reinforcement remained approximately
the same (N.S., Tukey Test) at both schedules (Table 1).
Clonidine intake at the FR-3 and FR-10 schedules of reinforcement was significantly below (p<:_.05; Tukey Test) that
observed at the FR-1 schedule of clonidine reinforcement.
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(p ~ .001; Tukey Test). Values a~e the mean + S.E. for 3 days at each FR requirement.

Table 1.

Effect of Increasing the Fixed Ratio (FR)
Requirement on the Total Daily Clonidine
Intake of One Rat.

Fixed Ratio Requirement

Clonidine Intake/Day 1
(mg/Kg)

1

1.28 + 0.17

3

0.71 + 0.13 2
0.60 + 0.012,3

10

1

values are the mean + S.E. for 3 days at each FR requirement.
2 significantly different (p < .05; Tukey Test)
clonidine intake at FR-1 requirement.

from

3Not significantly different (p~.05; Tukey Test)
clonidine intake at FR-3 requirement.
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from

Effect of Substituting Clonidine and Saline on Self-Administration Rates in Rats Previously Self-Administering
Fentanyl
As shown in Figure 5, substitution of clonidine so that
the subjects received 15 ug/Kg/injection maintained selfadministration behavior in rats previously self-administering fentanyl (1 ug/Kg/injection).

However, the substitution

of clonidine (1 ug/Kg/injection) or saline for the fentanyl
solution resulted in extinction of the self-administration
behavior.

One rat died within eleven hours following sub-

stitution of clonidine (15 ug/Kg/injection).

Effect of Adding Naloxone to the Clonidine and Fentanyl Solutions for Self-Administration of the Drug Mixture
As shown in Table 2, addition of naloxone to the clonidine and fentanyl solutions so that the subjects received
64 ug/Kg/injection produced a significant decrease

(p~

0 .01;

Scheffe's Test) in the self-administration rates of rats
previously self-administering fentanyl but did not on day 1
of addition, decrease the self-administration rates of
rats previously self-administering clonidine (p/O .05).
In rats previously self-administering fentanyl, rates of
self-administration remained significantly below (p<0.01;
Scheffe's Test) pre-naloxone rates while naloxone remained
mixed with the fentanyl solution.

Removal of naloxone

(post-naloxone) from the fentanyl solution resulted in a
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Table 2.

Effect of Adding Naloxone to the Clonidine and
Fentanyl Solutions for Self-Administration of
the Drug Mixture.l

DAY
PreNaloxone
Naloxone

%

Clonidine Alone 2

100 + 14 ( 3)
1

114 + 14 ( 3)
-

2

153 (2)

1

Fentanyl Alone

2

100 + 2 ( 3)
25 + 10 ( 3)

-

6 + 2 ( 3)
7 + 3 ( 3)

3

PostNaloxone

%

173 (2)

34 + 13(3)

2

88 + 28(3)

3

126 + 25(3)

1

Naloxone (64 ug/Kg/inj) was added to clonidine (15 ug/Kg/
inj) and fentanyl (1 ug/Kg/inj) solutions for selfadministration of the drug mixture on a CRF schedule.
2

Pre-naloxone value was obtained by taking the mean + S.E.
of the percentages of the mean number of lever presses of
the two days prior to adding naloxone for each rat. Other
values are mean + S.E. and are expressed as a percentage
of the pre-naloxone rate for the number of rats indicated
in parentheses. Only mean is presented where N was less
than three.
Decreasing N was the result of technical
difficulties.
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return towards pre-naloxone rates of self-administration.
Data indicated that self-administration rates following removal of naloxone (post-naloxone) from the fentanyl solution were not significantly different (P

~.05;

Scheffe's

Test) from self-administration rates before the addition
of naloxone (pre-naloxone)

to the fentanyl solution.

How-

ever, post-naloxone self-administration rates were significantly higher (p <::::0.01, Scheffe's Test) than the rates
of self-administration when naloxone was mixed with the
fentanyl solution.
In rats previously self-administering the clonidinenaloxone mixture, removal of naloxone from the clonidine
solution tended to result in an increase in self-administra tion rates above pre-naloxone rates.

Rates of self-

administration following the removal of naloxone did not
appear to increase above self-administration rates of
the clonidine-naloxone mixture,

however, the number of

subjects was too small to determine statistical significance.

Effect of Adding Haloperidol to the Clonidine and Fentanyl
Solutions for Self-Administration of the Drug Mixture
As presented in Table 3, the addition of haloperidol
to the clonidine and fentanyl solutions so that the subjects received 64 ug/Kg/injection resulted in a significant
decrease (p tt::'- 0.01; Scheffe's Test) in the self-administration rates of rats previously self-administering either
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Table 3.

Effect of Adding Haloperidol to the Clonidine and
Fentanyl Solutions for Self-Administration of the
Drug Mixture.l

DAY
PreHaloper idol
Haloperidol

%

Clonidine Alone

2

%

Fentanyl Alone

100 + 2 ( 7)
-

8 ( 4)
100 +
-

1

17 + 3 ( 7)
-

22 + 8 ( 4)
-

2

16 + 2 ( 5)
-

27 + 6 ( 3)
-

3

17 + 2 ( 5)
-

PostHaloperidol 1

65

( 2)

50

( 2)

2

70

(2)

103

(2)

3

83

(2)

4

95

(2)

2

1

Haloperidol (64 ug/Kg/inj) was added to clonidine (15 ug/Kg/
inj) and fentanyl ( ug/Kg/inj) solutions for self-administration of the drug mixture on a CRF schedule.
2

Pre-haloperidol values were obtained by taking the mean + S.E.
of the percentages of the mean of the two days prior to adding
haloperidol for each rat. Other values are mean + S.E. and
are expressed as percentage of the pre-haloperidol rate for
the number of rats indicated in parentheses. Only mean is
presented where N was less than three.
Decreasing N was the
result of technical difficulties.
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clonidine or fentanyl alone.

Depression of self-adminis-

tration rates was maintained below (p <::. 0.01; Scheffe's
Test) pre-haloperidol rates while haloperidol remained in
the clonidine and fentanyl solutions.

Self-administration

rates following the removal of haloperidol (post-haloperidol)

from the clonidine and fentanyl solutions tended to

return to pre-haloperidol rates, however the number of
subjects was too small to determine a statistical difference.

Effect of Adding Aceperone to the Clonidine and Fentanyl
Solutions for Self-Administration of the Drug Mixture
Addition of aceperone to the clonidine solution so that
the subjects received 64 ug/Kg/injection had no significant
effect (p ::::> 0. 05 Scheffe' s Test) on rates of self-administration in rats previously self-administering clonidine
alone (Table 4).

The rate of clonidine self-administration

of one rat following the removal of aceperone from the
clonidine solution was approximately the same as the preaceperone response rate for this rat.

Addition of aceper-

one to the fentanyl solution so that subjects received
64 ug/Kg/injection resulted in a significant increase
(pL.. 0.01; Scheffe's Test) in the rates of self-administration of rats previously self-administering fentanyl alone.
The rates of self-administration remained significantly
above (p<:::.0.01; Scheffe's Test) pre-aceperone rates while
aceperone remained in the fentanyl solution.

Removal of

aceperone from the f entanyl solution tended to result in
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Table 4. Effect of Adding Aceperone to the Clonidine and
Fentanyl Solutions for Self-Administration of
the Drug Mixture.l

DAY
PreAce per one
Aceperone

PostAceperone

% Clonidine Alone 2

% Fentanyl Alone

5 ( 3)
99 +
-

3 ( 5)
100 +
-

1

136 +
- 30 ( 3)

186 + 25(5)
-

2

5 ( 3)
146 +
-

221 + 5 3 ( 4)
-

3

125 + 12 ( 3)
-

238 + 51 ( 3)
-

1

83 (1)

251 ( 2)

2

94 (1)

320 (2)

3

88 (1)

408 (2)

2

1
Aceperone ( 64 ug/Kg/ inj) was added to clonidine (15 ug/Kg/
inj) and f entanyl ( 1 ug/Kg/inj) solutions for self-administration of the drug mixture on a CRF schedule.
2

Pre-aceperone values were obtained by taking the mean + S.E.
of the percentages of the mean of the two days prior to-adding aceperone for each rat.
Other values are mean + S.E. and
are expressed as percentage of the pre-aceperone rate for the
number of rats indicated in parentheses. Only mean is presented where N was less than three.
Decreasing N was the
result of technical difficulties.
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an increase in rates of self-administration above rates of
self-administration when aceperone was mixed with the
fentanyl solution.

However, the number of subjects was too

small to determine a statistical significance.

Effect of Adding Azaperone to the Clonidine and Fentanyl
Solutions for Self-Administration of the Drug Mixture
Addition of azaperone to the clonidine solution so
that the subjects received 64 ug/Kg/injection tended to
decrease the self-administration rates of rats previously
self-administering fentanyl alone (Table 5).

However, the

number of subjects was too small to determine a statistical
significance.

Addition of azaperone to the fentanyl solu-

tion so that the subjects received 64 ug/Kg/injection resulted in a significant decrease in the self-administration
rates of rats previously self-administering fentanyl alone.
The rates of self-administration remained below pre-azaperone rates while azaperone remained in the clonidine and
fentanyl solutions.

Removal of azaperone (post-azaperone)

from the clonidine and fentanyl solutions tended to produce
a return towards pre-azaperone rates of self-administration,
however, the number of subjects was not large enough to determine a statistical significance.
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Table 5.

Effect of Adding Azaperone to the Clonidine and
Fentanyl Solutions for Self-Administration of the
Drug Mixture.

DAY
PreAzaperone
Azaperone

PostAzaperone

% Clonidine Alone

100 + 19(2)

2

% Fentany l Alone 2

100 + 3 (4)

1

26

(2)

35 + 8(4)

2

30

(2)

44 + 8(4)

3

34

( 2)

22

( 1)

1

65

( 1)

96

(2)

2

93

( 1)

3

98

( 1)

1

Azaperone (64 ug/Kg/inj) was added to clonidine (15 ug/Kg/
inj) and fentanyl (1 ug/Kg/inj) solutions for self-administration of the drug mixture on a CRF schedule.
2

Pre-azaperone values were obtained by taking the mean + S.E.
of the percentages of the mean of the two days prior to-adding azaperone for each rat.
Other values are mean + S.E. and
are expressed as percentage of the pre-azaperone rate for the
number of rats indicated in parentheses. Only mean is presented where N was less than three.
Decreasing N was the
result of technical difficulties.
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DISCUSSION
Acquisition of Fentanyl Self-Administration
A number of narcotics (for review see Seiden and Dykstra,
1977) are known to maintain behavior leading to their administration (i.e. to act as positive reinforcers).
The rate and pattern of narcotic self-administration depends on several factors including the narcotic, dose per
injection, amount of time the drug is available, number of
responses required to obtain the drug injection or schedule
of reinforcement, experience of the subject and environmental
conditions.
Fentanyl is a synthetic narcotic which is approximately
80 times more potent than morphine as an analgesic (Jaffe
and Martin, 1975).

When an intravenous injection of fentanyl

(1 ug/Kg/injection) was made contingent on lever pressing,
drug-naive rats readily began to lever press to obtain injections of this drug; that is, they began to self-administer it.
Lever pressing to obtain fentanyl injections gradully increased over the first five days from a mean of 44 + 12
(N=21) lever presses on day one of self-administration to a
mean of 350 + 114 (N=l7) by day five of self-administration.
The mean number of lever presses to obtain fentanyl injections remained approximately the same from day five to day
seven.

Average daily fentanyl intake for these three days
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was 358 ug/Kg/day.

Therefore, i t is demonstrated that fen-

tanyl (1 ug/Kg/injection) will function as a positive reinforcer as it will maintain behavior leading to its administration.
Under conditions of unlimited access, similar to those
used in this investigation, Deneau et al.

(1969) examined

the pattern of morphine self-administration in rhesus monkeys.
It was observed that morphine intake in these subjects increased daily for 30 days after which it became stable.
Therefore, the pattern of fentanyl self-administration resembles the pattern of morphine self-administration in that
there was a steady increase in self-administration rate and
then a stabilization of self-administration rate for both
narcotics.

Since fentanyl is a much more rapidly acting

and more potent narcotic than morphine this may explain the
much faster acquisition and stabiliziation of fentanyl selfadministration.

In addition, the dose per injection of each

narcotic and the species difference certainly plays a role.
When intravenous injection of a lower dose (0.1 ug/Kg/
injection) of fentanyl was made contingent on lever pressing
subjects did not acquire self-administration behavior.

Thus,

suggesting that this dose of fentanyl does not possess reinforcing properties.
(0.1 ug/Kg/injection)

That rates of self-administration for
fentanyl were not significantly differ-

ent from self-administration rates when saline was available
supports this suggestion.
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Self-administration behavior in rats previously allowed
to self-administer fentanyl (0.1 ug/Kg/injection) was acquired
however when the higher dose (1 ug/Kg/injection) of fentanyl
was substituted.

Rates of self-administration on day four

of substitution were similar to rates of self-administration
in rats not allowed to self-administer the lower dose initially.

Thus a similar acquisition pattern for fentanyl

(1 ug/

Kg/injection) was observed regardless of whether or not the
subjects had previous experience in the operant chambers.
While self-administering fentanyl (1 ug/Kg/injection)
rats were alert and appeared healthy; occasionally, when the
injection system failed (i.e. cannula became disconnected
from the syringe) so that the subjects no longer received a
fentanyl injection with each lever press, some rats exhibited
narcotic withdrawal symptoms such as piloerection, diarrhea
and ''wet shakes."

The appearance and severity of these

symptoms depended on how long the subject had been selfadministering fentanyl and also on the subject's rate of
fentanyl self-administration.
of fentanyl (1 ug/Kg/injection)

Therefore, self-administration
can produce physiological

dependence as manifested by the appearance of a characteristic abstinence syndrome upon termination of narcotic administration.

It is doubtful, however, if physiological de-

pendence is a necessary condition for fentanyl to function as
a reinforcer as it has been previously reported that narcotics
can function as reinforcers at doses too low to produce physiological dependence (Schuster, 1968; Woods and Schuster
1968, 1971; Hoffmeister and Schlichting, 1972).
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This is

demonstrated by higher response rates at these doses than
when saline is available and also by the absence of withdrawal symptoms when the availability of narcotic injections is
discontinued.

Acquisition of Clonidine Self-Administration
As discussed earlier the majority of evidence indicates
that clonidine acts as an alpha-noradrenergic agonist in the
central nervous system and depending on the dose administered
may stimulate either pre- or post-synaptic noradrenergic receptors.

Low doses (4-8 ug/Kg i.v.) have been reported to

inhibit the firing of the noradrenergic neurons of the locus
coeruleus (Svennson et al., 1975) and thus a pre-synaptic
locus of action has been suggested, while higher doses (100
ug/Kg i.p.) have been suggested to stimulate post-synaptic
noradrenergic receptors (Anden et al., 1970).
When an intravenous injection of clonidine (15 ug/Kg/
injection) was made contingent on lever pressing, drugnaive rats readily began to lever press to obtain injections
of the drug.

The number of lever presses to obtain clonidine

injections gradually increased over the first three days of
self-administration from a mean of 69 + 22 (N=23)
presses on day one to a mean of 169 + 32 (N=l3)
by day three.

lever

lever presses

The mean number of lever presses to obtain

clonidine injections remained approximately the same from
day 3 to day 5.

Average daily clonidine intake for these

three days was 2.8 mg/Kg.
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The acquisition of clonidine self-administration was
faster than the acquisition of fentanyl self-administration
as demonstrated by a stable rate of clonidine-reinforced
responding being achieved before a stable rate fentanyl-reinforced responding (3 days vs. 5 days).

When daily intake

of each drug did become stable, however, average daily
clonidine intake was much higher than the average daily fentanyl intake (2.81 mg/Kg vs. 0.358 mg/Kg).
It cannot be stated with certainty whether or not the
dose of clonidine self-administered by rats is stimulating
pre- or post-synaptic noradrenergic receptors; however, behavioral and sympathomimetic signs exhibited by the rats suggest that clonidine may be stimulating post-synaptic noradrenergic receptors.

If clonidine were stimulating pre-

synaptic noradrenergic receptors this would inhibit norepinephrine release from noradrenergic nerve endings thus leading
to reduced transmission in the noradrenergic system.

It has

been suggested that an action on pre-synaptic receptors could
account for clonidine's depressant action on locomotor and/
or exploratory activity (Laverty and Taylor, 1969; Maj et al.,
1972; Strombom, 1976; Tilson, 1977).

On the contrary, how-

ever, rats self-administering clonidine were highly excitable and made erratic movements when disturbed, leaping up
into the roof of the operant chambers.

If the door of the

operant chamber were left open the subjects would try desperately to escape, thus demonstrating that locomotor and/or
exploratory activity was not decreased.
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In fact, exploratory

may actually have increased as rats self-administering saline
or fentanyl do not try to escape from the chamber when the
door is left open.

Clonidine has been reported to potentiate

escape attempts induced by naloxone in morphine-dependent
rats

(Tseng et al., 1975), and to produce hyperactivity in

mice following intraperitoneal administration of a large
(5-30 mg/Kg) dose (Razzak, 1975).
While self-administering clonidine the subjects exhibited
marked sympathomimetic signs such as exopthalamus and piloerection. These and other sympathomimetic signs such as,
horripilation, tremor, and hyperactivity have been reported
(Hoefke and Kobinger, 1966; Morpurgo, 1968; Razzak, 1975)
when doses from 30-100 ug/Kg i.v. or 1-30 mg/Kg i.p. were administered to mice.

Furthermore, Morpurgo (1968) reported

that administration of the alpha-noradrenergic receptor blocker
phentolamine reversed the sympathomimetic signs.
A liquid was noted to be secreted from the eyes of subjects self-administering clonidine and eye pigmentation was
observed to change
color.

~rom

a black color to an orange-brownish

In cats and monkeys intravenous administration of

clonidine (10 ug/Kg) was reported to reduce eye pressure in
such a way that indicated marked vasoconstriction (Bill and
Heilmann, 1975).

Furthermore, Knapp and Galloway (1975) re-

ported that the eyes of a patient taking several drugs for
hypertension, one of which was clonidine, began to turn a
reddish color.

However, a beta-blocker and not clonidine was

thought to be responsible for this ocular reaction.
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Constipation is a known side effect of clonidine and indeed subjects self-administering clonidine became severely
constipated as evidenced by the absence of fecal matter on
the wood shavings underneath the floor of the operant chamber.
Dix and Johnson (1977) reported that rats chronically
treated with clonidine maintained a poor coat condition. Subjects self-administering clonidine also maintained a poor coat
condition.

Occasionally, when the injection system failed

and the subject no longer received clonidine injections upon
lever pressing, symptoms such as "wet shakes" and diarrhea
were observed.

Saperia (1975) reported that a man was troub-

led by diarrhea for four days following consumption of a large
amount (5 mg) of clonidine.
Clonidine has been reported to produce irritability and
aggression in mice and rats (Morpurgo, 1968; Laverty and
Taylor, 1969; Dix, 1977) and also to enhance morphine-withdrawal and apomorphine-induced aggression in rats (Gianutsos
et al., 1976).

Rats self-administering clonidine assumed an

attack posture and demonstrated aggressiveness towards the
experimenter when a gloved hand was put into the operant
chamber.

Morpurgo (1968) reported that the clonidine-induced

aggression was blocked by dopamine receptor antagonists such
as haloperidol but poorly antagonized by norepinephrine receptor blockers and therefore concluded that the aggressiveness appears to be independent of clonidine's sympathomimetic
effects.
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When access to cocaine was unlimited, Deneau et al.,
(1969) reported that monkeys would self-administer the drug
until convulsions and death occurred, usually within 30 days.
Similarly , approximately 22% of subjects self-administering
clonidine did so until death occurred, and this invariably
occurred on day one of self-administration.

Profuse saliva-

tion and complete loss of eye pigmentation was noted in these
subjects.

Several cases of clonidine overdose have been re-

ported in humans (Saperia, 1975; Wing et al., 1975; Hunyor
et al., 1975; Moore and Philipi, 1976); however in none of
these reports did overdose lead to death.

Human overdose was

always accompanied by severe hypertension and it was suggested (Wing et al., 1975) that the clonidine overdose is a
result of dominance of the peripheral alpha-agonist action
of this drug (Rand and Wilson, 1968) over its central hypotensive effects.

Bradycardia was also noted in each case of

human overdose and was treated by administration of atropine.
Therefore, the cardiovascular effects of clonidine may be
responsible for the death of subjects self-administering it.
Since clonidine will maintain behavior leading to its
administration in rats, it can be said to act as a positive
reinforcer.

Behavioral and sympathomimetic signs exhibited

by rats self-administering clonidine suggest that the drug
is stimulating post-synaptic noradrenergic receptors.
Effect of Increasing the Fixed-Ratio Requirement on Clonidine
Self-Administration Behavior
In general experiments investigating the effect of
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schedules of reinforcement on drug self-administration demonstrate that drug reinf orcers generate response rates and patterns characteristic of rates and patterns generated by other
reinforcers such as food or water (McKearney and Morse, 1964;
Thompson and Schuster, 1964; Woods and Schuster, 1968; Pickens
and Thompson, 1971, 1972; Goldberg, 1973; Dougherty and
Pickens, 1973; Balster and Schuster, 1973; Anderson and Thompson, 1974; Downs and Woods, 1974; Iglauer and Woods, 1974;
Goldberg et al., 1975; Goldberg and Kelleher, 1976; for review (see Spealman and Goldberg, 1978), electric shock (McKearney, 1968, 1969, 1970), or termination of a stimulus
associated with occasional electric shocks (Kelleher and
Morse, 1964; Morse and Kellhe b , 1966).
Intravenous administration of drugs of several pharmacological classes, including narcotic analgesics, narcotic
antagonists, barbiturates and benzodiazepines dissociative
anesthetics and psychomotor stimulants, has maintained responding by laboratory animals under fixed ratio:

(FR)

schedules of reinforcement (for review see Spealman and
Goldberg, 1978).
Delivery of an intravenous clonidine injection maintained responding in drug-naive rats when the drug was delivered on a FR-1 schedule of reinforcement.

When the FR

requirement to obtain each clonidine injection was increased
from 1 to 3 responses per reinforcement, total daily clonidine
intake decreased even though a significant increase in responding was observed.

When the FR requirement was further
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increased to FR-10, however, responding increased so that
total daily clonidine intake at the FR-3 and FR-10 schedules
of reinforcement were the sar.ie.
Similar observations were made by Weeks (1962) who examined morphine intake under different FR schedules of reinforcement.

When the FR requirement to obtain each morphine

injection was increased from 1 to 5, morphine intake decreased even though responding to obtain the drug increased.
However, when the FR requirement was increased to an FR-10,
response rate doubled from its FR-5 level so that morphine
intake remained the same at the FR-5 and FR-10 schedules of
morphine reinforcement.
Goldberg et al.

(1971) increased the FR requirement for

rhesus monkeys to obtain each intravenous pentobarbital injection from 1 to 3 to 5 to 10 and observed a corresponding
decrease in both response rate and total pentobarbital intake as the FR requirement was increased.

Thus, even though

both clonidine (Nickerson and Ruedy, 1975) and pentobarbital
(Harvey, 1975) produce central nervous system depression,
the effect of increasing the FR requirement on clonidine
self-administration behavior does not resemble the effect of
increasing the FR requirement on pentobarbital self-administration behavior.

These differential results may possibly

suggest that the neurochemical mechanisms underlying the reinforcing properties of clonidine and pentobarbital are
different.
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When the psychomotor stimulants cocaine (Pickens, 1968;
Pickens and Thompson, 1968; Goldberg et al., 1971) and amphetamine (Pickens and Harris, 1968) are delivered on FR schedules
of reinforcement an increase in responding is observed as
the FR requirement is increased so that total intake of these
drugs remains constant. Therefore, in some respects the effect of increasing the FR requirement to obtain clonidine injections resembles the effect of increasing the FR requirement
to obtain psychomotor stimulants as increasing FR requirement
to obtain each clonidine injection from 3 to 10 resulted in
an increase in responding so that total clonidine intake remained the same at these FR schedules of reinforcement.

Effect of Substituting Clonidine and Saline on Self-Administration Behavior in Rats Previously Self-Administering Fentanyl
It has recently been reported that clonidine and morphine
have similar pharmacological effects on noradrenergic neurons
(Gomes et al., 1976; Redmond, 1977).

Of relevance to this

discussion are the findings that both clonidine and morphine
inhibit the firing of the noradrenergic nucleus locus coeruleus
(Svensson et al., 1975; Korf, 1974) and that opiate receptors
are located on locus coeruleus cell bodies (Kuhar et al.,
1974).
Recently, Redmond et al.

(1976) and Redmond (1977) re-

ported that the effects of electrical or pharmacological activation of locus coeruleus in monkeys were strikingly similar
to those noted after opiate withdrawal in humans (anxiety
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state) .

Both clonidine and morphine blocked the effects of

activation of the locus coeruleus (Redmond, 1977) and furthermore the time course correlated with the decreased neuronal
activity in locus coeruleus (Svennson et al., 1975; Cedarbaum
and Aghajanian, 1976; Cedarbaum and Aghajanian, 1977) and
decreased norepinephrine release (Braestrup, 1974; Maas et
al., 1976) produced by these drugs.

Clonidine has been demon-

strated to decrease certain narcotic withdrawal signs, such
as body shakes, induced by discontinuation of narcotic administration (Fielding et al., 1977; in press) or by administration of narcotic antagonists (Tseng et al., 1975;
Vetulani and Bednarczyk, 1977) in morphine-dependent rats.
Gold et al.

(1978) reported that clonidine eliminated opiate

withdrawal signs in narcotic addicts and that all of the subjects in the study reported dramatic relief of distress.

In

an earlier study Bjorkqvist (1975) reported that clonidine
decreased the sweating, tremor and anxiety accompanying alcohol withdrawal in humans.
Also of interest is the finding that clonidine produces
analgesia in rats and mice (Paalzow, 1974; Paalzow and Paalzow,
1976; Fielding et al., 1977; in press) and that the antinociceptive effects of clonidine are not reversed by naloxone
(Paalzow and Paalzow, 1976; Fielding et al.,

in press) sug-

gesting that clonidine does not bind to opiate receptors.
The above reports suggesting a similarity between clonidine and narcotics are particularly interesting in view of
the fact that self-administration behavior was maintained in
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rats self-administering the narcotic fentanyl when clonidine
(15 ug/Kg/injection) was substituted for the fentanyl solution.
In general, all drugs that are abused by man are selfadministered by laboratory animals, while the reverse does
not always hold true the similarities between clonidine and
narcotics noted above and the abuse of narcotics by humans
and their self-administration by laboratory animals suggest
that clonidine may have abuse potential.

There are no re-

ports of clonidine abuse among people, however, this could
be due to its route of administration (orally) and also its
prescription for hypertension.
patients in the Gold et al.

It is very interesting that

(1978) study chose to be main-

tained on clonidine rather than methadone upon discharge
from the hospital. While the authors do not report on the subjective effects produced by clonidine in these opiate addicts, the subjective effects are of considerable importance.
It could be that intravenous administration of clonidine by
narcotic addicts produces the same subjective effects,
''euphoria," as those produced by narcotics.

However, cloni-

dine does not generalize to morphine in rats trained to discriminate morphine from saline (Lal et al., 1977).

There-

fore, clonidine may not produce the same subjective effects
as narcotics since these effects are considered related to
their discriminative stimulus properties (Lal and Gianutsos,
1976; Lal et al., 1977), although in these discrimination
studies both clonidine and morphine were administered
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intraperitoneally.

It cannot be stated with certainty there-

fore whether or not clonidine produces the same subjective
effects as narcotics when administered intravenously.
One subject died within eleven hours of the substitution
of clonidine (15 ug/Kg/injection) for fentanyl.
loss of eye pigmentation (eyes white) was noted.

Complete
In another

rat the substitution of clonidine (15 ug/Kg/injection) led
to self-mutilation of the forelimbs.

Razzak (1975) reported

that intraperitoneal administration of a large dose (50 mg/Kg)
of clonidine produced self-mutilation in mice.
Self-administration was not maintained in rats previously self-administering fentanyl; however, when a lower dose of
clonidine (1 ug/Kg/injection) or saline was substituted for
the fentanyl solution, Thompson and Pickens (1970) noted that
when the opportunity to self-administer a narcotic or a psychomotor stimulant was withdrawn, there was an initial increas.e in responding followed by a gradual decrease.

The

increase in responding following the discontinuation of administration of a positive reinforcer is referred to as an
"extinction burst."

This phenomenon was noted when clonidine

(1 ug/Kg/injection) was substituted for fentanyl.

On

day

one of substitution of clonidine (1 ug/Kg/injection) an increase in responding above that observed for fentanyl alone
was noted, thereafter responding gradually declined.
Substitution of saline for the fentanyl solution also
produced extinction of lever pressing behavior; however, no
extinction burst was observed.

This could be because lever
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pressing was measured every 24 hours and therefore an initial
increase in lever pressing during the early hours of substitution was masked.

Winger et al.

(1975) reported that re-

sponding decreased less rapidly when saline was substituted
for drug than when responding had no consequence.

The some-

what different extinction patterns observed following the
substitution of clonidine (1 ug/Kg/injection) and saline for
the f entanyl solution could therefore be due to the mere
presence and absence of drug effect as perceived by the subject.

Effect of Adding Naloxone to the Clonidine and Fentanyl Solutions for Self-Administration of the Drug Mixture
Narcotic antagonists are effective in preventing and
reversing the pharmacological actions of opiates and can
elicit narcotic-withdrawal in opiate-dependent organisms.
Naloxone can be considered a relatively pure opiate antagonist which produces no discernable subjective effects when
administered to non-opiate dependent subjects (Jaffe and
Martin, 1975).
As mentioned earlier, clonidine produces several pharmacological actions similar to narcotics.

Therefore, it was

of interest to examine the effect of naloxone on clonidine
and fentanyl self-administration behavior.
When added to the clonidine solution so that the subjects received 64 ug/Kg/injection, naloxone did not decrease
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rates of self-administration of rats previously self-administering clonidine (15 ug/Kg/injection) alone.

These

findings are in agreement with the results of the recent studies of Paalzow and Paalzow (1976) and Fielding et al.

(1977,

in press) which derronstrate that clonidine-induced analgesia
is not antagonized by naloxone.
with the report of Meyer et al.

They are also consistent
(1977) who demonstrated that

naloxone; in doses capable of suppressing operant behavior,
causing body weight loss and other symptoms of withdrawal in
morphine-dependent rats (Gellert and Sparber, 1977), failed
to disrupt operant behavior in clonidine-dependent rats.
Therefore, clonidine's reinforcing effects do not appear to
be mediated through an interaction at the opiate receptor.
In another study investigating the effect of a narcotic
antagonist on the self-administration of a non-narcotic drug,
Goldberg et al.

(1972) reported that nalorphine had no effect

on rates of cocaine self-administration in monkeys.
Narcotic antagonists have been demonstrated to maintain
responding that postpones or terminates their administration
(i.e. to act as negative reinforcers) in morphine-dependent
monkeys (Goldberg,1971,1972; Downs and Woods, 1975; Woods
et al., 1975) and rats

(Smith, 1973).

In drug-naive animals

narcotic antagonists with weak antagonistic properties such
as pentazocine and propiram will maintain behavior leading
to their administration (i.e. to act as positive reinforcers)
(Woods and Villareal, 1970; Hoffmeister and Schlichting,
1972; Goldberg et al., 1972) while narcotic antagonists with
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strong antagonistic properties such as cyclazocine and nalorphine do not function as positive reinforcers (Deneau et al.,
1969; Hoffmeister and Schlichting, 1972) and may act as negative reinforcers (Hoffmeister and Wuttke, 1973) .
Low doses of narcotic antagonists have been reported to
increase morphine self-administration (Weeks and Collins,
1964; Thompson and Schuster, 1964; Goldberg et al., 1969,
1971, 1972) while high doses decrease responding to obtain
morphine injections (Goldberg et al., 1972).

Furthermore,

narcotic antagonists have been demonstrated to block the
ability of narcotics to impart secondary reinforcing properties on previously neutral stimuli (Davis and Smith, 1974;
Marcus et al., 1976).
When naloxone was added to the fentanyl solution so
that the subjects received 64 ug/Kg/injection there was a
significant decrease in the self-administration rates of
rats previously self-administering fentanyl (1 ug/Kg/injection) alone.

Response rates remained significantly sup-

pressed below pre-naloxone rates while naloxone remained in
the fentanyl solution but gradually returned toward prenaloxone rates when naloxone was removed from the fentanyl
solution.

Similar results were obtained by Woods et al.

(1975) who examined the effect of response-contingent naloxone injections on codeine-reinforced responding in rhesus
monkeys.

Naloxone produced a dose-dependent decrease in

codeine-reinforced responding when added to the codeine

98

solution for self-administration of the codeine-naloxone
mixture.

Furthermore, codeine-reinforced responding re-

mained suppressed while naloxone remained in the codeine
solution and gradually returned to pre-naloxone rates over
three sessions following removal of naloxone. Woods et al.,
(1975) suggest that response-contingent naloxone injections
function as a punishing stimulus which decreases selfadministra tion (lever pressing) behavior.

Since almost

identical results were obtained in this and the Woods et
al. study, decreased fentanyl-reinforced responding following addition of naloxone to the fentanyl solution may also
be explained by the punishing effects of response-contingent
naloxone injections.
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Effect of Adding Some Butyrophenone to the Clonidine and
Fentanyl Solution for Self-Administration of the Drug Mixt~e

1.

Haloperidol
Chemically, haloperidol is the prototype of the buty-

rophenone series of neuroleptic compounds (Janssen, 1967).
The ED 50 values for haloperidol in the norepinephrine and
amphetamine antagonism tests in rats are 2.10 and 0.38
mg/Kg, respectively (Janssen and Van Bever, 1978).

Thus

haloperidol is an extremely potent antagonist of dopamine
receptors, a property which affords this drug tremendous
efficacy in the treatment of psychoses.
Hanson and Cimini-Venema (1972) reported that low doses
of haloperidol (0.6 mg/Kg, twice daily) increased morphine
self-administration in rats while doses of 0.24 mg/Kg and
higher, twice daily, significantly decreased morphine selfadministration.

Similarly, Pozuelo and Kerr (1972) re-

ported that haloperidol decreased morphine intake in morphinedependent monkeys and Glick and Cox (1975) reported a doserelated antagonism of morphine self-administration produced
by haloperidol.

Utilizing a conditioned reinforcement test,

Smith and Davis (1975) demonstrated that haloperidol-induced
decreases in morphine self-administration was the result of
a motor deficit and was not the result of antagonism of the
reinforcing action of morphine.

However, investigations of

the effects of neuroleptics on psychomotor stimulant selfadministra tion (Davis and Smith, 1975; Yokel and Wise,
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1975, 1976) indicate that neuroleptics attenuate the reinforcing effects of this class of drugs at doses which do
not produce motor deficits.
The results of these studies suggest that haloperidol
and other neuroleptics may have potential value in the
treatment of narcotic and psychomotor stimulant abuse. This
suggestion is supported by the finding that amphetamine
euphoria is reduced after pimozide, a diphenulbutylpiperidine neuroleptic (Janssen et al., 1968), administration to
humans (Gunne et al., 1972).

Furthermore, Karkalas and Lal

(1973) reported that haloperidol suppressed heroin abstinence and reduced craving for the drug.
Lever pressing rates of rats previously self-administering clonidine (15 ug/Kg/injection) or fentanyl (1 ug/Kg/
injection) alone significantly decreased when haloperidol
was added to the clonidine and f entanyl solutions so that
the subjects received 64 ug/Kg/injection.

The addition of

haloperidol did not preferentially affect clonidine- or
fentanyl-reinforced responding; rather, haloperidol produced a similar reduction in lever pressing when added to
either drug solution.

Suppression of clonidine- and

fentanyl-reinforced responding remained stable while haloperidol remained in the drug solutions.

Clonidine- and

fentanyl-reinforced responding tended to return to prehaloperidol rates upon removal of haloperidol from both
drug solutions; however, the number of subjects was too
small to determine statistical significance.
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Unfortunately, all of the animal studies cited above
measured the effect of subcutaneous or intraperitoneal administration of neuroleptics on narcotic and psychomotor
stimulant self-administration, whereas making a direct comparison between the effect of adding the neuroleptic haloperidol to the clonidine and fentanyl solutions is diff icult.

The addition of haloperidol to the clonidine and

fentanyl solutions could have decreased response rates in
rats previously self-administering clonidine and fentanyl
alone for several reasons.
Investigations of the neurochemical basis for reinforcement resulting from the self-administration of narcotics
(Davis and Smith, 1972; Davis and Smith, 1973a; Glick et
al., 1973) and psychomotor stimulants (Davis and Smith,
1972; Davis and Smith, 1973b) have implicated central catecholaminergic brain mechanisms.

Attempts to discriminate

between brain noradrenergic and dopaminergic mechanisms
suggest the involvement of noradrenergic receptors in opiate reinforcement (Davis et al., 1975), while both noradrenergic and dopaminergic receptors appear to be involved
in psychomotor stimulant reinforcement (Davis et al., 1975;
Davis and Smith, 1975).

In view of the known anti-cate-

cholaminergic activity of haloperidol it could be suggested
that decreased self-administration rates in rats previously
self-administering either clonidine or fentanyl alone

~e

the result of attenuation of the reinforcing property underlying the action of these drugs.
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Neuroleptics are also known, however, to produce sedation and motor deficits.

Therefore, reduced lever pressing

produced by haloperidol may be the result of a performance
deficit.

Wise (1978) has reviewed evidence showing that

neuroleptics interfere with reward processes at doses that
do not cause significant performance impairment.

Wise

states that "data from studies of intravenous stimulant reward suggest the use of moment to moment analysis of the
pattern of neuroleptic effects ... ".

This type of analysis

is to prevent the incorrect observations which can result
~hen

sion.

response rates are measured over an entire test sesFor example, Yokel and Wise (1975, 1976) reported

that low doses of the neuroleptic drugs pimozide and
(+)butaclamol increased lever pressing for intravenous
amphetamine injections.

Higher doses produced an initial

increase in lever-pressing followed by cessation of responding.

The authors suggest that low doses of neuroleptics

decrease the rewarding effects of amphetamine and that
subjects increase lever pressing to overcome the neuroleptic attenuation of the rewarding effects.
were suggested to completely

Higher doses

block the rewarding effects

and thus following an initial extinction burst, gradual
extinction of lever pressing is observed.

A respons,e

pattern similar to the latter occurs when saline is substituted for a drug reinforcer.

Had response rates been

averaged over the entire session, however, Yokel and Wise
would not have made the same observations since response
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rates in these studies were depressed over the entire test
session.

Since the effect of adding haloperidol on lever

pressing rate in rats previously self-administering either
clonidine or f entanyl alone was measured over a 24 hour
period an initial increase in response rate (an indicator
of reward attenuation) would have been masked, therefore
it cannot be stated with certainty whether or not haloperidol was decreasing the reinforcing property of clonidine
and fentanyl or was producing sedation and motor deficits.
Finally, by definition, punishment is said to have
occurred when the future probability of behavior that precedes the delivery of the punishing stimulus is reduced
(Azrin and Holz, 1966).

Therefore, the addition of haloper-

idol to the clonidine and fentanyl solutions could have
produced a punishing (aversive) stimulus which resulted in
the reduction of lever pressing so observed.

2.

Aceperone
Aceperone is a butyrophenone neuroleptic which is

virtually devoid of anti-dopaminergic activity (Janssen
et al., 1967; Janssen, 1978) and should be considered as
a specific alpha-adrenergic blocking agent and not as an
antipsychotic (Janssen and Van Bever, 1978).

ED 50 values

for aceperone in the norepinephrine and amphetamine antagonism tests in rats are 0.60 and
(Janssen and Van Bever, 1978).
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160 mg/Kg, respectively

When aceperone was added to the clonidine solution,
so that the subjects received 64 ug/Kg/injection, no significant change in the rates of self-administration of
rats previously self-administering clonidine (15 ug/Kg/
injection) alone was observed.

As discussed earlier, the

marked sympathomimetic signs exhibited by rats self-administering clonidine and results of other investigators
suggested that the reinforcing action of clonidine was
mediated by an interaction of post-synaptic alpha-noradrenergic receptors.

Therefore, one would expect that the

alpha-noradrenergic receptor antagonist, aceperone , would
have some effect on the reinforcing effects of clonidine.
Braestrup (1974) reported that aceperone produced a significant increase in the brain concentration of the major
norepinephrine metabolite, 3-methoxy-4-hydroxy-phenylglycol (MOPEG) , while clonidine significantly decreased
MOPEG concentration.

It is suggested by Braestrup (1974)

that aceperone increases release of norepinephrine while
clonidine decreases norepinephrine release.
Aceperone- and clonidine-induced changes in norepinephrine release may be accomplished by two mechanisms.
Blockade of either pre- or post-synaptic alpha-noradrenergic
receptors by aceperone would lead to increased norepinephrine
release while stimulation of either

pre~

or post-synaptic

receptors by clonidine would lead to a decrease in norepinephrine release.

Thus, if clonidine were stimulating
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post-synaptic receptors and aceperone were blocking postsynaptic receptors one would expect antagonism of the reinforcing action of clonidine by aceperone.

However, if

clonidine were stimulating post-synaptic receptors and
aceperone were blocking pre-synaptic receptors, no antagonism would be expected.

In fact,

the latter mechanism

could be hypothesized to result in potentiation of the
reinforcing action of clonidine.

The differential affinity

of aceperone for the pre- and post-synaptic alpha-adrenergic receptors is not known.

It may also be suggested that

both drugs are acting at the post-synaptic receptor but
the dose of aceperone is insufficient to antagonize clonidine' s agonist action.

Clearly, more work is needed to

investigate these results.

The use of other alpha-adren-

ergic receptor blockers with differential actions at the
pre- and post-synaptic such as piperoxane and phenoxybenzamine would be of interest.
When aceperone was added to the f entanyl solution so
that the subjects received 64 ug/Kg/injection a significant (approximately two-fold)

increase in the response

rates of rats previously self-administering fentanyl (1 ug/Kg/
injection) alone was observed.

The rates of self-adminis-

tration remained fairly stable and significantly above preaceperone rates, while aceperone remained in the fentanyl
solution.

These results could be interpreted in two ways.

As mentioned earlier, low doses of neuroleptics are reported
to increase narcotic and psychomotor-stimulant self106
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administration, while higher doses produce an initial increase in responding followed by a decrease in drug selfadminis tration (Hanson and Cimini-Venema, 1972; Yokel and
Wise, 1975, 1976).

It was suggested that low doses of

neuroleptics produce a partial blockade of the reinforcing
actions of these drugs and thus subjects increase rates of
self-administration to overcome the attenuation, while
higher doses produce complete blockade of the reinforcing
effects which after an extinction burst leads to extinction
of the self-administration behavior.

Since the noradrener-

gic system has been implicated in mediating the reinforcing
actions of narcotics (Davis and Smith, 1975), blockade of
alpha-noradrenergic receptors by aceperone could lead to
attenuation of the reinforcing action of fentanyl and thus
subjects increase lever pressing to overcome the aceperone
action.

If this interpretation is correct, then increasing

the dose of aceperone added to the fentanyl solution should
eventually produce complete blockade of the reinforcing
effects of fentanyl and thus extinction of fentanyl selfadministration.
An alternative interpretation, however, is that adding
aceperone to the fentanyl solution makes the drug combination more reinforcing than fentanyl alone. Again,
Braestrup (1974) suggested that aceperone increase norepinephrine release.

This action could be seen to potentiate

the reinforcing actions of narcotics which are suggested to
be mediated through the noradrenergic system (Davis and
Smith, 1975).
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The latter interpretation may explain the increase
in response rate observed when aceperone was removed from
the fentanyl solution.

Weeks and Collins (1964) reported

that in physiologically dependent rats, self-administering morphine reducing the injection dose resulted in an
increase in the number of injections taken.

Thus if add-

ing aceperone to the fentanyl solution increases the reinforcement per injection then decreasing the reinforcement
per injection by removing aceperone fromthefentanyl solution could result in a compensatory increase in lever
pressing such as was observed.

It should be noted, how-

ever, that a sufficient number of subjects to determine
statistical significance of post-aceperone data was not
achieved.

3.

Azaperone
Azaperone is a sedative neuroleptic of the butyrophen-

one series with outstanding anti-aggressive and anti-shock
activity in animals (Niemegeers et al., 1974).

The effec-

tive dose 50 (Eo 50 ) for azaperone in the norepinephrine
antagonism test (a measure of anti-noradrenergic activity)
in rats is 0.33 mg/Kg while the ED 50 value for azaperone
in the amphetamine antagonism test (a measure of antidopaminergic activity) in rats is 2.5 mg/Kg (Niemegeers
et al., 1974; Janssen and Van Bever, 1978). Therefore,
azaperone is a more potent antagonist of noradrenergic receptors than of dopaminergic receptors.
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Lever pressing rates of rats previously self-administering either clonidine (15 ug/Kg/injection) or fentanyl
(1 ug/Kg/injection)

tended to decrease when azaperone was

added to the respective drug solutions so that the subjects received 64 ug/Kg/injection.

Addition of azaperone

did not preferentially affect clonidine- or fentanyl-reinforced responding; rather, azaperone tended to produce a
similar reduction in lever pressing when added to either
drug solution.

Suppression of clonidine- and fentanyl-

reinforced responding remained stable while azaperone remained in the drug solutions.

Fentanyl- and clonidine-

reinforced responding tended to return to pre-azaperone
rates when azaperone was removed from the clonidine and
fentanyl solutions.

It should be noted however, that the

number of subjects was too small to determine a statistical significance.
Like haloperidol, the addition of azaperone to the
clonidine and fentanyl solutions may result in a decrease
in response rates for three reasons.

First, azaperone

could antagonize the reinforcing actions of clonidine and
fentanyl which leads to the observed decrease in selfadministra tion behavior.

Since azaperone is a potent

catecholamine receptor antagonist non-specific motor deficits produced by the drug could produce the decreased
response rates.

Again, since response rate was measured

over a 24-hour period one cannot determine whether azaperone
decreased the rewarding action of clonidine and fentanyl as
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as an initial increase in lever pressing (an indicator
of reward attenuation) would have been masked.
Neuroleptics of the butyrophenone- and phenothiazinetype are well known to produce dysphoric effects in nonschizophrenic human beings (Janke and Debus, 1968).

Fur-

thermore, both types of neuroleptics have been demonstrated
to maintain behavior leading to their termination or nonoccurrence (i.e. to act as negative reinforcers) in rhesus
monkeys (Hoffmeister, 1975; Hoffmeister and Wuttke, 1975;
Hoffmeister, 1977).

Therefore, perhaps the best explana-

tion for the decreased response rates observed is that the
addition of azaperone to the clonidine and fentanyl solutions forms a punishing stimulus which results in a reduction in lever pressing behavior.
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SUMMARY AND CONCLUSIONS
In summary i t was demonstrated that laboratory rats
will self-administer the alpha-noradrenergic receptor agonist clonidine when a dose of 15 ug/Kg/injection is made
contingent on a continuous reinforcement schedule.

That

clonidine was self-administered for its positive reinforcing property and not because of the drug's non-specific
behavioral effects was demonstrated by an increase in the
response rate to obtain clonidine injections as the response requirement to obtain each clonidine injection was
increased.
It was also demonstrated that rats will self-administer fentanyl (1 but not 0.1 ug/Kg/injection).

Extinction

of self-administration behavior in rats self-administering
fentanyl following the substitution of saline for the
fentanyl solution indicates that fentanyl was self-administered for its positive reinforcing effects.
In rats self-administering fentanyl (1 ug/Kg/injection),
it was demonstrated that substitution of clonidine (15 but
not 1 ug/Kg/injection)

for the fentanyl solution maintained

self-administration behavior.
Pilot experiments demonstrated that addition of the
narcotic antagonist naloxone to the clonidine and fentanyl
solutions resulted in a significant decrease in fentanyl111

reinforced responding but did not appear to decrease clonidine-reinforced responding.

These data suggest that

clonidine reinforcement is mediated by opioid independent
mechanisms.

Preliminary experiments also demonstrated that

addition of haloperidol and azaperone to the clonidine and
fentanyl solutions tended to result in a decrease in clonidine- and fentanyl-reinforced responding; however, the
exact nature of this effect was unclear.

Similarly, in a

pilot experiment it was determined that addition of aceperone to the clonidine and fentanyl solutions had no effect
on clonidine-reinforced responding but resulted in a twofold increase in fentanyl-reinforced responding.

The

exact basis of these results remains to be determined.
In conclusion, self-administration of the alpha-noradrenergic receptors agonist clonidine and increased selfadministration rates to obtain clonidine injections as the
response requirement to obtain each clonidine injection was
increased suggests that stimulation of alpha-noradrenergic
receptors can result in positive reinforcement.

All drugs

that are abused by humans are self-administered by laboratory animals and most drugs that are self-administered by
laboratory animals are self-administered by man.

There-

fore, intravenous self-administration of clonidine by rats
suggests that clonidine may possibly possess abuse potential by humans if self-administered intravenously.

Also,

because of the known abuse of narcotics by humans, maintainence by clonidine of self-administration behavior of
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rats previously self-administering the synthetic narcotic
fentanyl supports this suggestion.
Preliminary experiments suggest that fentanyl- and
clonidine-reinf orced responding are similarly affected by
the addition of haloperidol and azaperone to the fentanyl
and clonidine solutions.

However, the exact nature of

these effects remains to be determined.

Furthermore, pre-

liminary experiments with aceperone suggest that fentanyland clonidine-reinforced responding are affected differentially by the addition of aceperone to the fentanyl and
clonidine solutions.

Finally, decreased fentanyl- but

not clonidine-reinforced responding by response-contingent
naloxone injections suggests that clonidine reinforcement
is not mediated by opioid dependent mechanisms.
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